<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title>Frontiers in Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnins.2025.1466166</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Abnormal response to chronic social defeat stress and fear extinction in a mouse model of <italic>Lynx</italic>2-based cholinergic dysregulation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Anderson</surname> <given-names>Kristin R.</given-names></name>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/664333/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Rogu</surname> <given-names>Peter J.</given-names></name>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2848940/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Palumbo</surname> <given-names>Talulla B.</given-names></name>
<uri xlink:href="https://loop.frontiersin.org/people/2896370/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Miwa</surname> <given-names>Julie M.</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/583703/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff><institution>Department of Biological and Chemical Sciences</institution>, <addr-line>Bethlehem, PA</addr-line>, <country>United States</country></aff>
<author-notes>
<fn id="fn0002" fn-type="edited-by"><p>Edited by: Jacob Raber, Oregon Health and Science University, United States</p></fn>
<fn id="fn0003" fn-type="edited-by"><p>Reviewed by: Hossein Aleyasin, Icahn School of Medicine at Mount Sinai, United States</p>
<p>Lei Xiao Gao, Chonbuk National University, Republic of Korea</p></fn>
<corresp id="c001">&#x002A;Correspondence: Julie M. Miwa, <email>jmm312@lehigh.edu</email></corresp>
<fn fn-type="present-address" id="fn0001"><p><sup>&#x2020;</sup>Present address: Kristin R. Anderson, Department of Biological and Chemical Science, University of Galway, Galway, Ireland</p>
<p>Peter J. Rogu, New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, United States</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>04</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>19</volume>
<elocation-id>1466166</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>07</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>01</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Anderson, Rogu, Palumbo and Miwa.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Anderson, Rogu, Palumbo and Miwa</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Nicotinic receptor signaling is influential in modulating appropriate responses to salient stimuli within a complex environment. The cholinergic neurotransmitter system drives attention to salient stimuli such as stressors, and aids in orchestrating the proper neural and behavioral responses. Dysregulation of this system, however, has been implicated in altered anxiety regulation and mood disorders. Among the multiple layers of regulation are protein modulators such as Lynx2/Lypd1, which provides negative nicotinic acetylcholine receptor regulation within anxiety-related circuits, such as the amygdala and medial prefrontal cortex, among other brain regions. Mice null for Lynx2/Lypd1 (Lynx2 KO) show elevated basal anxiety-like behavior in tests such as elevated plus maze, light-dark box and social interaction assays. Here, we queried how a line predisposed to basal anxiety-like behavior would respond to specific stressors, using validated models of experiential-based affective disorders such as fear extinction, acute and chronic social defeat stress assays. We discovered that Lynx2 KO mice demonstrate an inability to extinguish learned fear during fear extinction tests even during milder stress conditions. In social defeat studies, contrary to our predictions, the Lynx2 KO mice switched from a socially avoidant phenotype (which could be considered susceptible) before defeat to a social approach/resilient phenotype after defeat. Consistent with reports of the inverse relationship between resilience and BDNF levels, we observed reduced BDNF levels in the VTA of Lynx2 KO mice. Furthermore, we provide evidence for the functional role of &#x03B1;7 nicotinic receptor subtypes by phenotypic rescue of fear extinction and social defeat phenotypes by MLA antagonism of &#x03B1;7 nicotinic acetylcholine receptors, or by crossing with &#x03B1;7 nicotinic acetylcholine receptor null mutant mice. A stable physical interaction between LYNX2 and &#x03B1;7 nAChRs was observed by co-immunoprecipitation of complexes from mouse amygdalae extracts. Together, these data indicate that responses to specific stressors can become aberrant when baseline genetic factors predispose animals to anxiety dysregulation. These studies underscore the critical nature of well-regulated nicotinic receptor function in the adaptive response to environmental stressors.</p>
</abstract>
<kwd-group>
<kwd>nAChR</kwd>
<kwd>Lynx2</kwd>
<kwd>LYPD1</kwd>
<kwd>social interaction</kwd>
<kwd>anxiety behavior</kwd>
<kwd>nicotinic acetylcholine receptors</kwd>
<kwd>CSDS</kwd>
<kwd>defeat stress</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="1"/>
<ref-count count="88"/>
<page-count count="15"/>
<word-count count="13070"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neuropharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>The stress response is an adaptive suite of physiological and psychological changes that helps an individual to galvanize appropriate responses to threatening situations (<xref ref-type="bibr" rid="ref73">Robinson et al., 2019</xref>). If not regulated properly, however, individuals can develop persistent, pervasive, and generalized anxiety or fear in the form of an affective disorder that is detrimental to quality of life (<xref ref-type="bibr" rid="ref27">Grogans et al., 2023</xref>) and which can lead to maladaptive damage in the long-term and comorbidities such as depression (<xref ref-type="bibr" rid="ref52">Maron and Nutt, 2017</xref>; <xref ref-type="bibr" rid="ref75">Schneiderman et al., 2005</xref>). The capacity to moderate one&#x2019;s response to stressors&#x2014;to balance adaptive protection in the short term and maladaptive changes in the long term&#x2014;is critical as disorders involving anxiety and fear are among the most prevalent mental disorders, affecting 33.7% of US adults at some point in their lives (<xref ref-type="bibr" rid="ref53">McEwen, 2017</xref>; <xref ref-type="bibr" rid="ref78">Stein et al., 2017</xref>; <xref ref-type="bibr" rid="ref27">Grogans et al., 2023</xref>; <xref ref-type="bibr" rid="ref38">Kessler et al., 2012</xref>). Despite the high prevalence of affective disorders, current treatments do not meet the full need, highlighting the utility of further understanding the complex underpinnings of anxiety to inform the development of effective treatments.</p>
<p>The cholinergic system is an important modulatory neurotransmitter system involved in a number of adaptive behaviors. Nicotinic acetylcholine receptors (nAChRs) of the cholinergic system have been shown to regulate activity in anxiety, fear, and depressive-related circuits and related behaviors in animal studies (<xref ref-type="bibr" rid="ref0071">Mineur et al., 2023</xref>; <xref ref-type="bibr" rid="ref56">Mineur and Picciotto, 2019</xref>; <xref ref-type="bibr" rid="ref67">Pang et al., 2016</xref>; <xref ref-type="bibr" rid="ref37">Jiang et al., 2016</xref>; <xref ref-type="bibr" rid="ref83">Wilson and Fadel, 2017</xref>). The use of nicotine has been demonstrated to both increase and decrease anxiety, in various contexts (<xref ref-type="bibr" rid="ref45">Kutlu and Gould, 2015</xref>; <xref ref-type="bibr" rid="ref0071">Mineur et al., 2023</xref>; <xref ref-type="bibr" rid="ref55">Mineur et al., 2016</xref>; <xref ref-type="bibr" rid="ref69">Picciotto, 2003</xref>). People report self-medicating with nicotine products to alleviate anxiety (<xref ref-type="bibr" rid="ref20">Ferraz Lima et al., 2023</xref>), and there is an association between genes of the nicotinic receptor system and anxiety (<xref ref-type="bibr" rid="ref23">Gillentine et al., 2018</xref>; <xref ref-type="bibr" rid="ref51">Markett et al., 2011</xref>). LYNX2, a nicotinic modulatory protein, is encoded by the <italic>Lynx2</italic>/<italic>Lypd1</italic> gene, expressed in key regions of anxiety and fear circuitry, such as the amygdala and medial prefrontal cortex, in addition to other CNS sites (<xref ref-type="bibr" rid="ref17">Dessaud et al., 2006</xref>; <xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>; <xref ref-type="bibr" rid="ref76">Sherafat et al., 2021</xref>), and sites outside the nervous system (<xref ref-type="bibr" rid="ref77">Song et al., 2024</xref>; <xref ref-type="bibr" rid="ref63">Omori et al., 2024</xref>). The LYNX2 protein binds to and reduces the activity of nAChRs (<xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>; <xref ref-type="bibr" rid="ref84">Wu et al., 2015</xref>) in response to its natural ligand, acetylcholine, as well as the drug of abuse, nicotine. The <italic>Lynx2</italic> null mutant mouse (<italic>Lynx2</italic>KO) displays heightened fear and anxiety-like behavior across several paradigms of basal anxiety, including light&#x2013;dark box, elevated plus and social interaction tests (<xref ref-type="bibr" rid="ref76">Sherafat et al., 2021</xref>; <xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>), and changes in an acoustic startle response in male <italic>Lynx2</italic>KO mice (<xref ref-type="bibr" rid="ref76">Sherafat et al., 2021</xref>). Removal of <italic>Lynx2</italic> leads to hyperactivity of nAChR responses, sensitizing nAChR to agonist and slowing receptor desensitization (<xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>). We posited that an imbalance of nicotinic signaling is playing a role in the heightened basal anxiety-like behavior, which can influence situational or specific threats in the environment (<xref ref-type="bibr" rid="ref62">O&#x2019;Leary et al., 2013</xref>). The development of affective disorders often results from long-term adaptation to dynamic and complex conditions (such as basal anxiety and context). Therefore, we sought to probe how heighted nAChR activity in anxiety-related circuits (<xref ref-type="bibr" rid="ref7">Calhoon and Tye, 2015</xref>; <xref ref-type="bibr" rid="ref3">Anderson and Adolphs, 2014</xref>) might contribute to longer-term adaptive responses in Lynx2 KO mice, employing fear extinction and social defeat stress behavioral paradigms.</p>
<p>Neural mechanisms allow the encoding of salient events into memories by associative learning processes, and these help us respond later to cues that may predict a threat. This can be experimentally assessed by a fear conditioning paradigm that pairs an innocuous conditioned stimulus, such as a tone, with an unconditioned stimulus, such as a shock (<xref ref-type="bibr" rid="ref29">Heged&#x00FC;s et al., 2022</xref>). Since these processes employ coincidence detection to encode a suite of associated events into memories, however, not all encoded cues are predictive. New experiences which thwart conditioned expectations allow us to update learned associations that might be coincidental and not causative. Extinction of conditioned fear is an active learning process that produces a new association, integrating the conditioned association into a safety memory and is accompanied by a reduction in a conditioned fear response (<xref ref-type="bibr" rid="ref0070">Bouton et al., 2021</xref>; <xref ref-type="bibr" rid="ref48">Lissek et al., 2004</xref>; <xref ref-type="bibr" rid="ref26">Grillon, 2008</xref>; <xref ref-type="bibr" rid="ref13">Craske et al., 2014</xref>; <xref ref-type="bibr" rid="ref22">Furini et al., 2014</xref>). Cholinergic neurons respond to unexpected sensory cues that play a role in fear learning and extinction (<xref ref-type="bibr" rid="ref29">Heged&#x00FC;s et al., 2022</xref>; <xref ref-type="bibr" rid="ref30">Herry et al., 2008</xref>; <xref ref-type="bibr" rid="ref14">Crimmins et al., 2023</xref>). Elevations in nAChR signaling in the amygdala have been shown to inhibit fear extinction, whereas nAChR inhibition there promotes it (<xref ref-type="bibr" rid="ref37">Jiang et al., 2016</xref>), underscoring the need of regulating nAChR activity. Fear extinction provides insight into the complex interactions that basal state of anxiety impacts on learning and responses to a specific threat.</p>
<p>Social stress is a pervasive form of stress experienced by most animals and is a known component of many human affective disorders such as depression and anxiety (<xref ref-type="bibr" rid="ref21">Fiksdal et al., 2019</xref>; <xref ref-type="bibr" rid="ref43">Krishnan et al., 2007</xref>). An etiologically relevant paradigm of conflict for the rodent species is the chronic social defeat stress test (CSDS), where test mice undergo daily defeat sessions characterized by both physical bouts and extended sensory contact with an aggressor mouse (<xref ref-type="bibr" rid="ref25">Golden et al., 2011</xref>; <xref ref-type="bibr" rid="ref32">Hultman et al., 2016</xref>; <xref ref-type="bibr" rid="ref5">Bagot et al., 2016</xref>). CSDS is a highly validated assay that produces two divergent stress responses in social interaction tests, resilient, approaching the aggressor mouse, versus susceptible, avoiding it (<xref ref-type="bibr" rid="ref6">Berton et al., 2006</xref>; <xref ref-type="bibr" rid="ref46">Lagace et al., 2010</xref>; <xref ref-type="bibr" rid="ref25">Golden et al., 2011</xref>; <xref ref-type="bibr" rid="ref33">Hultman et al., 2018</xref>; <xref ref-type="bibr" rid="ref5">Bagot et al., 2016</xref>; <xref ref-type="bibr" rid="ref32">Hultman et al., 2016</xref>). The resilience response to CSDS has been shown to increase upon nicotine exposure via a mechanism involving BDNF, a trophic factor implicated in many neuroplasticity processes (<xref ref-type="bibr" rid="ref58">Khalifeh et al., 2020</xref>; <xref ref-type="bibr" rid="ref49">Mallei et al., 2019</xref>; <xref ref-type="bibr" rid="ref65">Pagliusi et al., 2018</xref>). It has also been shown that CSDS elicits BDNF release in the ventral tegmental area (VTA) in susceptible wild-type mice (<xref ref-type="bibr" rid="ref41">Koo Wook et al., 2016</xref>; <xref ref-type="bibr" rid="ref40">Koo et al., 2019</xref>). While the VTA, a midbrain dopaminergic structure, is not considered a part of the primary anxiety-related circuit, it has an important role in many processes, including assessing the difference between expectation and outcome, and neuroplastic changes underling it (<xref ref-type="bibr" rid="ref2">Anacker et al., 2016</xref>; <xref ref-type="bibr" rid="ref82">Wang et al., 2023</xref>; <xref ref-type="bibr" rid="ref8">Cao et al., 2010</xref>).</p>
<p>We probed the extent to which the dysregulation of nAChRs in anxiety-related circuits and subsequent heightened basal anxiety in <italic>Lynx</italic>2 KO mice would alter the complex behaviors of fear extinction and social defeat (<xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>; <xref ref-type="bibr" rid="ref76">Sherafat et al., 2021</xref>). Our prediction was that their heightened baseline anxiety-related phenotype would disproportionately affect their response to fear extinction and social defeat. To begin to address the mechanism, we studied the effect of <italic>Lynx2</italic> removal on nAChR signaling and any subsequent changes in BDNF.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<title>Materials and methods</title>
<sec id="sec3">
<title>Animal model</title>
<p>All animal procedures were conducted in accordance within the guidelines of Lehigh University IACUC to ensure the humane and ethical treatment of the animals. Animals were kept on a 12/12-h light&#x2013;dark cycle with ad libitum access to food and water. Animals were weaned at 21&#x202F;days of age and separated by sex into group housing ranging from 2 to 5 animals per cage. A total of 3- to 8-month-old na&#x00EF;ve, male and female, wild-type (WT) (C57BL/6&#x202F;J), <italic>Lynx2</italic>KO, and double null mutant mice for the &#x03B1;7 nAChR and <italic>Lynx2</italic> (&#x03B1;7/<italic>Lynx</italic>2 double KO mice) were used. Breeding of the <italic>Lynx2</italic>KO mice included null mutant crosses to create knockout mice for experiments, backcrosses the C57BL/6J mice (C57) to maintain genetic diversity and avoid genetic drifts, and crosses of <italic>Lynx2</italic> heterozygous mice from the backcrosses to other <italic>Lynx2</italic> heterozygous mice from different pairs or knockout mice to refresh to the null mutants. The backcross was introduced every three generations. The &#x03B1;7/<italic>Lynx2</italic> double KO mice were created by crossing <italic>Lynx2</italic>KO null mutant mice with &#x03B1;7 null mutant mice. Litters from first generation double heterozygous (<italic>Lynx2</italic> +/&#x2212; &#x03B1;7 +/&#x2212;) mice were crossed together, and second-generation mice were genotyped to find either one allele as a null mutant (&#x2212;/&#x2212;) and the other allele as heterozygous (+/&#x2212;) or for double mutants (D&#x2212;/&#x2212; or D+/&#x2212;). Combinations of the possible genotypes [such as <italic>Lynx2</italic>KO (&#x2212;/&#x2212;), <italic>&#x03B1;</italic>7 heterozygous (+/&#x2212;) and <italic>Lynx2</italic> heterozygous (+/&#x2212;) and &#x03B1;7KO (&#x2212;/&#x2212;)] were crossed until several double mutants were verified. The double mutants were crossed to create mice for experiments. Backcross to C57BL/6&#x202F;J mice were added every three generations and added into the breeders as described before to avoid genetic drift. All mice were genotyped using a polymerase chain reaction assay from DNA that was extracted from a tail biopsy. Each tissue sample was genotyped 2&#x2013;3 times before the confirmed genotype was assigned. All mice were involved in one behavioral assay.</p>
</sec>
<sec id="sec4">
<title>Statistics and graphs</title>
<p>Power analysis was conducted before data collection. For all statistical analyses, a <italic>&#x03B1;</italic>&#x202F;=&#x202F;0.05 was used to establish a statistically significant result.</p>
<p>For fear extinction experiments, data were collected as the number of seconds spent freezing during the behavior trial on day 1 and day 2 of extinction. This was divided by the total amount of time in the chamber and multiplied by 100% to obtain the % freezing on each day. These data are represented by line graphs. A two-tailed paired Student&#x2019;s <italic>t</italic>-test was performed on the set of observations on day 1 of extinction and the set of observations on day 2 of extinction in order to determine if there was a significant reduction in freezing. As a measure of fear extinction, the percentage freezing on day 2 was subtracted from the percentage freezing on day 1. Thus, the reduction in % freezing could be compared between groups such as sex and genotype. This was done using the R anova_test() function to compute one- or more-way ANOVA, depending on the number of variables being evaluated for their effect. <italic>Post-hoc</italic> Student&#x2019;s <italic>t</italic>-tests were conducted when a significant result was obtained. These datasets are represented by boxplots. For the 5-day extinction trials shown in 1b, these line graphs were simply extended to have 5&#x202F;days on the x-axis. A repeated measures ANOVA was performed on the set of observations to determine whether there was a significant reduction in freezing across days.</p>
<p>For chronic social defeat stress experiments, data were collected as seconds spent in the interaction zone before and after the novel mouse is added. Time spent in the interaction zone with a C57 stranger mouse versus the CD1 aggressor is graphed on a boxplot with individual data points. SI ratios were calculated by dividing the time in the interaction zone with a stranger present by the time in the interaction zone with no stranger present. SI ratios are shown on a boxplot with a scatter plot overlaid. Paired two-tailed Student&#x2019;s <italic>t</italic>-tests were performed on the SI ratios between the C57 baseline interaction and the CD1 aggressor interaction after CSDS. Unpaired two-tailed Student&#x2019;s <italic>t</italic>-tests were performed to assess the effect of genotype on SI ratios at each time point. Mice were assigned as either resilient or susceptible based on the SI ratio of a certain trial. Fisher&#x2019;s exact test was performed on the distribution among these groups.</p>
<p>Western blots were scanned using a ChemiDoc imaging system using the stain-free gel program and analyzed using ImageJ. Molecular weight of bands was determined by dividing the location of each band on the standard by the length of the gel. This was plotted on the y-axis against the logarithm of the known molecular weights of the standards. A line of best fit could be generated from this scatter plot. Then, the quotient associated with the distance traveled along the gel of the sample bands can be fit to this line, the x-value solved for, and the exponent of this value determined. The relative intensity of BDNF in samples as compared to actin can be determined by taking the pixel intensity of each band, as well as the space directly above and below it as a control. The intensity of the BDNF band was divided by the intensity of the actin band, and these values were plotted on a bar graph, with error bars representing the standard error among the digital measurements. No statistical analysis was performed on this gel since only one replicate of the gel was run.</p>
<p>All major behavioral assays were performed with a minimum of three replicates or independent cohorts to ensure a biological phenomenon as opposed to a one-time result. Replicates were temporally separated tests, and each included a different set of wild-type and knockout mice. All data are given as 95% confidence intervals (CIs) and are represented as AVG&#x202F;&#x00B1;&#x202F;SEM. &#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;05, &#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01, and &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001.</p>
</sec>
<sec id="sec5">
<title>Fear conditioning</title>
<p>Fear conditioning and extinction is a 3-day experiment carried out in a conditioning hub (Coulbourn Instruments) where mice were placed inside an isolation cubicle (Coulbourn Instruments) to prevent ambient light and sound interference. The hub environment was lined with silver metallic walls, washed with isopropyl alcohol between trials, and had a mounted shock floor. On day 1, mice were placed in the cubicle and underwent a 2-min acclimation which consists of 2, 30&#x202F;s sound (80&#x202F;dB and 8&#x202F;kHz) presentations, 2&#x202F;min apart (20 WT mice, male; <italic>n</italic>&#x202F;=&#x202F;10, female, <italic>n</italic>&#x202F;=&#x202F;10; 19 <italic>Lynx2</italic> KO mice, male, <italic>n</italic>&#x202F;=&#x202F;9; female, <italic>n</italic>&#x202F;=&#x202F;10). To induce fear conditioning, during the last 2&#x202F;s of the sound, the animal received a mild (0.5&#x202F;mA) foot shock, with a 30-s rest period after the last foot shock, and the animals were returned to their home cage. For the weaker fear extinction paradigm, mice received only 1 tone-shock pairing at 0.25&#x202F;mA shock. This was run with a different set of mice than the 2 tone-shock pairing. Fear conditioning is a day of learning for mice, and they learn to expect that the shock will follow when a tone is heard.</p>
</sec>
<sec id="sec6">
<title>Fear extinction</title>
<p>After the first day of fear conditioning, day 2 and 3 fear extinction took place, with multiple measures taken to control for context. Mice were placed in a different cubicle than the one used for day 1 of fear conditioning, the walls of the hub were switched to colorful patterns, a lavender scent was introduced, and between trials, the cubicle was washed with the novel cleaning agent, ethanol. This creates a different environment for the mouse and leaves the tone as the only constant. After 30&#x202F;s of acclimation in the extinction chamber, the animal was presented with 3 sound presentations at the same frequency and intensity as on the training day, each 30&#x202F;s long and 2&#x202F;min apart, but with no foot shocks.</p>
<p>The behavior of the mice was recorded using an in-hub camera, and time spent freezing was analyzed using Coulbourn FreezeFrame software. The data are collected based on freezing, which was considered to be no bout of movement in a 2-s frame. A minimum cutoff value of 50% freezing on day 1 was used to eliminate mice that did not show freezing behavior. The criteria for an extinguished fear response were a statistically significant decrease in percent freezing to tone (CS) between day 2 (Ext 1) and day 3 (Ext 2).</p>
<p>To confirm data, we extended the test from 2&#x202F;days to 5&#x202F;days following the same procedures. Mice were placed in a different cubicle than the one used for day 1 of fear conditioning, the walls of the hub were switched to colorful patterns, a lavender scent was introduced, and between trials, the cubicle was washed with the novel cleaning agent, ethanol. This creates a different environment for the mouse and leaves the tone as the only constant. After 30&#x202F;s of acclimation in the extinction chamber, the animal was presented with 3 sound presentations at the same frequency and intensity as on the training day, each 30&#x202F;s long and 2&#x202F;min apart, but with no foot shocks.</p>
</sec>
<sec id="sec7">
<title>Fear conditioning and extinction with pharmacological treatment</title>
<p>Fear conditioning was performed as previously described but with the addition of an IP injection given to <italic>Lynx2</italic>KO mice and WT mice 1&#x202F;h prior to fear extinction on days 2 and 3. Mecamylamine (Mec) (a non-specific nAChR blocker), Methyllycaconitine (MLA) (an &#x03B1;7 antagonist), and Dihydro-&#x03B2;-erythroidine (DH&#x03B2;E, a &#x03B2;2&#x002A; nAChR antagonist) can cross the blood&#x2013;brain barrier at several documented doses, with enough potency to produce changes to nAChR function (<xref ref-type="bibr" rid="ref81">Turek et al., 1995</xref>; <xref ref-type="bibr" rid="ref16">Damaj et al., 1995</xref>). Doses were chosen based upon such studies. Mec (0.3&#x2013;2.5&#x202F;mg/kg, Abcam, Cambridge, MA), DH&#x03B2;E (2&#x202F;mg/kg, Tocris Bioscience, Bristol, UK), and MLA (5&#x202F;mg/kg, Sigma &#x2013; Aldrich, St Louis, MA) were dissolved in 0.9% saline. The control animals were injected with 0.9% saline. Successful fear extinction was defined as a decrease in percent freezing from Ext 1 to Ext 2. Ext 2 is analyzed as the final extinction time point.</p>
</sec>
<sec id="sec8">
<title>Light&#x2013;dark box</title>
<p>The light&#x2013;dark box assay was conducted in TruScan motion tracking arena (Coulbourn Instruments). A dark walled box was placed inside the back half of the arena with the front half surrounded by clear walls. An arched opening was made between the two areas. <italic>Lynx2</italic>KO or WT mice were initially placed in the light side, and their location was monitored for 10&#x202F;min by the TruScan software. Mice show an increase in anxiety-like behavior when spending an extended period in the dark causing an increased latency. For pharmacological studies, mice were given an injection, IP, 1&#x202F;h prior to the start of testing.</p>
</sec>
<sec id="sec9">
<title>Chronic social defeat stress</title>
<p>CSDS followed a method adapted from the standardized protocol (<xref ref-type="bibr" rid="ref25">Golden et al., 2011</xref>), with the CD1 mouse strain used as aggressors (<xref ref-type="bibr" rid="ref31">Hsieh et al., 2017</xref>). First, CD1 mice were singly housed for 7&#x202F;days followed by a screen for aggression over 3&#x202F;days. During each day of screening, an 8 to 20-week-old WT male mouse was added to the home cage of the CD1, and the latency of the CD1 to attack is recorded. The WT mouse was removed upon attack or after 3&#x202F;min. An attack was defined as a physical altercation that included, but was not limited to, biting, shoving, rushing, jumping onto tail rattling, and kicking. CD1 aggressors must show aggression in at least 2 subsequent sessions and have an attack latency of less than 60&#x202F;s to be considered as an aggressor.</p>
<p>We set up two groups: non-defeated and defeated mice. Non-defeated mice (WT, <italic>Lynx2</italic>KO, &#x03B1;7/Lynx2double KO (&#x03B1;7/L2 double KO) were housed with littermates after weaning. They were placed in the same room as defeated mice and not disturbed until they were used for social interaction. For defeat, test mice (WT, <italic>Lynx2</italic>KO, &#x03B1;7/<italic>Lynx2</italic>double KO) were exposed to a CD1 aggressor mouse for a daily bout of 10 attacks. The attacks were limited to 10 to prevent excessive harm to the test mice that was observed with a defined time window. Following the bout, the intruder mouse was physically separated from the CD1 aggressor within the CD1 home cage but kept in sensory contact for 24&#x202F;h. This was repeated each day for 10&#x202F;days, after which, the test mice were singly housed for 24&#x202F;h to await behavioral testing.</p>
</sec>
<sec id="sec10">
<title>Acute social defeat stress</title>
<p>We adapted the 10-day CSDS to test the robustness and sensitivity of the post-defeat phenotypes in this particular genetic model of anxiety-like behavior. We carried out the same procedure as described above in CSDS, but the defeat sessions occurred over 3&#x202F;days. After the 3rd day of defeat, the test mice were singly housed. We found that the 3&#x202F;days were sufficient to induce enough of a response in the test mice that conferred with the matching behavioral results of the 10-day protocol.</p>
</sec>
<sec id="sec11">
<title>Social interaction</title>
<p>The social interaction (SI) test occurred 24&#x202F;h after the defeat session ended and mice were singly housed. SI ratios were assessed in Coulbourn TruScan motion tracking arenas. The arena was calibrated with an interaction zone against the back-most wall, and a wire containment cage was built to the specifications of the protocol (<xref ref-type="bibr" rid="ref25">Golden et al., 2011</xref>).</p>
<p>For each phase of social interaction test, post-defeat mice or controls (na&#x00EF;ve WT and <italic>Lynx2</italic>KO mice that did not undergo defeat and were kept in the standard housing of 2&#x2013;5 littermates), called defeated or non-defeated test mice, respectively, were placed in the center arena and tracked for 150&#x202F;s. The initial phase consisted of an empty interaction zone cage. Immediately following the completion of phase 1, the test mouse was removed from the arena and returned to its home cage. During the break, a novel CD1 stranger mouse was added to the wire containment cage within the interaction zone. The same test mouse was again placed in the center of the arena and tracked for 150&#x202F;s. During this second phase, sensory information could be transmitted from the stranger to the test mouse, but there was no physical contact.</p>
<p>The location of the test mouse was tracked by the TruScan software. Social interaction ratios were determined based on time in the target zone (24 &#x00D7; 14 &#x00D7; 9&#x202F;cm box surrounding the interaction zone) with and without the stranger mouse present. The social interaction (SI) ratio was used to assign the test mouse to a group: resilient or susceptible. The SI ratio is calculated by the following formula:</p>
<disp-formula id="E1"><mml:math id="M1"><mml:mi>S</mml:mi><mml:mi>I</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext mathvariant="italic">Time</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">spent</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">in</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">interaction</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">zone</mml:mtext><mml:mo>,</mml:mo><mml:mtext mathvariant="italic">stranger</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">present</mml:mtext></mml:mrow><mml:mrow><mml:mtext mathvariant="italic">Time</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">spent</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">in</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">interaction</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">zone</mml:mtext><mml:mo>,</mml:mo><mml:mtext mathvariant="italic">empty</mml:mtext><mml:mspace width="0.25em"/><mml:mtext mathvariant="italic">zone</mml:mtext></mml:mrow></mml:mfrac></mml:math></disp-formula>
<p>For these studies, an SI ratio above 1.5 was considered &#x201C;resilient&#x201D; or &#x201C;approach&#x201D; and below 1.5 &#x201C;susceptible&#x201D; or &#x201C;avoidant&#x201D; rather than the standard 1 as the <italic>Lynx2</italic>KO mice were shifted toward higher SI ratios. We choose an SI ratio of 1.5 as our cutoff to increase the criteria needed to reach the resilient phenotype. Upon separating the groups, the data are presented as the percentage of time spent in the interaction zone with the stranger mouse present.</p>
<p>Test mice first underwent a CD1 social interaction test with a CD1 stranger mouse on day 11. The stranger mice used in the social interaction were either na&#x00EF;ve to the test mouse, or in some cases for the CD1, the stranger was the most remote CD1 aggressor to that test mouse, from day 1 of CSDS. Only males were used in these studies due to the difficulty of initiating attack behavior directed toward female mice (<xref ref-type="bibr" rid="ref79">Takahashi et al., 2017</xref>).</p>
</sec>
<sec id="sec12">
<title>Co-immunoprecipitation (co-IP)</title>
<p>WT, <italic>Lynx2</italic>KO, and &#x03B1;7KO mice were anesthetized with isoflurane and rapidly decapitated. The BLA was bilaterally dissected using visual landmarks and immediately homogenized in the bullet blender tissue homogenizer (NextAdvance, Averill Park, NY, USA), with Co-IP buffer (50&#x202F;mM Tris, 150&#x202F;mM NaCl, 0.75% Triton-X 100, Pierce protease inhibitor cocktail). Dynabeads A (Thermo Fisher Scientific, Waltham, MA, USA) were pre-incubated with 5&#x202F;&#x03BC;g rabbit anti-lypd1 (LYNX2) primary antibodies (Thermo Fisher Scientific, Waltham, MA, USA) and thoroughly washed. An input sample of each homogenate was removed and kept at &#x2212;80 degrees Celsius until Western blot analysis. Brain homogenates were incubated at a concentration of 13&#x202F;mg/mL with the Dynabeads-antibody complex for 3&#x202F;days nutating at RT. After washing, LYNX2 (LYPD1) protein complexes including interacting proteins were eluted and immediately prepared for Western blot analysis. Input (sample prior to the immunoprecipitation) and supernatant (after the immunoprecipitation) lane were to be compared to IP samples in the Western blot analysis. Co-immunoprecipitation experiments were performed in three replicates, each with one <italic>Lynx2</italic>KO mouse and two WT mice for a total of 18 technical replicates with 9 animals. The <italic>Lynx2</italic>KO mice were used as a negative control for the LYPD1 antibody. The &#x03B1;7KO mice were used as a negative control for the &#x03B1;7 antibody (data not shown).</p>
</sec>
<sec id="sec13">
<title>Western blot analyses</title>
<p>Samples were denatured in 1x sample buffer (Thermo Fisher Scientific, Waltham, MA, USA) at 95&#x00B0;C and run on a 4&#x2013;20% gradient SDS-PAGE gel (Bio-Rad Laboratories, Hercules, CA, USA). Gels were transferred onto activated PVDF membrane via a semi-dry transfer. The membrane was blocked with 5% milk/0.05% Tween-PBS for 1&#x202F;h at 4&#x00B0;C followed by an incubation overnight at 4&#x00B0;C in mouse monoclonal anti-nicotinic acetylcholine receptor &#x03B1;7 Subunit (1:1000, Sigma-Aldrich, St Louis, MO) or rabbit polyclonal anti-BDNF (5&#x202F;&#x03BC;g/mL, Millipore, Burlington, MA, USA) for the BDNF study. After thorough washing, membrane was incubated with conjugated goat anti-mouse (Abcam, Cambridge, MA, USA) at 1:10,000 for 2&#x202F;h at 4&#x00B0;C or 1:10,000 or conjugated goat anti-rabbit (Abcam, Cambridge, MA, USA) at 1:10,000 for 2&#x202F;h at 4&#x00B0;C for BDNF study. Membranes were incubated in ECL (Thermo Fisher Scientific, Waltham, MA, USA) and exposed to film. Loading controls were run using mouse anti-actin primary antibodies (Abcam, Cambridge, MA, USA) at 1:1000 dilution and goat anti-mouse secondary antibodies (Life Technologies, Carlsbad, CA, USA) at 1:40,000 dilution.</p>
</sec>
</sec>
<sec id="sec14">
<title>Results section</title>
<sec id="sec15">
<title>The loss of <italic>Lynx2</italic>, in a <italic>Lynx2</italic>KO mouse, leads to a robust lack of fear extinction</title>
<p>To discern how <italic>Lynx2</italic>KO mice responded in a paradigm that requires the updating of previously learned associations in response to new information, we tested the <italic>Lynx2</italic>KO in a fear extinction paradigm. Mice were trained by being subjected to two pairings of an innocuous tone and a foot shock and, 24&#x202F;h later, were tested for freezing behavior in response to the tone alone (CS). Extinction trials were presented over 2&#x202F;days, three CS trials per day. Over the course of fear extinction, <italic>Lynx2</italic>KO mice (red line) do not undergo fear extinction as demonstrated by the maintenance of freezing over the 2 extinction days. WT mice (black line), on the other hand, undergo fear extinction, measured as a reduction in freezing from extinction day 1 to day 2. A one-way repeated measures ANOVA was conducted, and there was a significant effect of genotype [<italic>p</italic>&#x202F;=&#x202F;0.011, Wilks&#x2019; Lambda&#x202F;=&#x202F;0.766, <italic>F</italic><sub>(1, 34)</sub>&#x202F;=&#x202F;7.918]. Two paired <italic>t</italic>-tests were used for <italic>post-hoc</italic> comparisons. There was significantly greater freezing in <italic>Lynx2</italic>KO (73.93 +/&#x2212; 1.84%) as compared to WT mice (68.75 +/&#x2212; 2.81%) on day 1 of extinction (paired samples <italic>t</italic>-test, t (35)&#x202F;=&#x202F;35.07, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001). On day 2 of extinction, the <italic>Lynx2</italic>KO mice (73.04 +/&#x2212; 1.66%) also showed greater freezing than WT (58.88 +/&#x2212;2.2822%), paired samples <italic>t</italic>-test, <italic>t</italic>(35)&#x202F;=&#x202F;32.757, <italic>p</italic>&#x202F;&#x003C;&#x202F;0001. WT <italic>n</italic>&#x202F;=&#x202F;20, L2KO <italic>n</italic>&#x202F;=&#x202F;19, WT 95% CI [51.548, 64.224], L2KO 95% CI [69.536, 76.310], Cohen&#x2019;s d&#x202F;=&#x202F;1.535. Two-way ANOVA for sex&#x002A;genotype <italic>F</italic>&#x202F;=&#x202F;0.743, <italic>p</italic>&#x202F;=&#x202F;0.395 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption><p>Marked lack of fear extinction in <italic>Lynx2</italic>KO mice. <bold>(A)</bold> Over the course of fear extinction, <italic>Lynx2KO</italic> mice (red line) do not undergo fear extinction as demonstrated by the maintenance of the degree of freezing between extinction day 1 and day 2. WT mice (black line) do undergo fear extinction, decreasing freezing over the course of 2 extinction days (<italic>p</italic>&#x202F;=&#x202F;0.011, one-way repeated ANOVA). The <italic>Lynx2</italic>KO mice show higher amounts of freezing on both extinction days 1 (&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.01) and 2 (&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001) as compared to WT mice. Y-axis is the % freezing to tone (CS) during the test period. <bold>(B)</bold> No sex differences were observed in fear extinction tests (<italic>p</italic>&#x202F;=&#x202F;0.0787). The reduction in freezing behavior from day 1 to day 2 was 8.334 +/&#x2212; 1.180% in WT males (<italic>n</italic>&#x202F;=&#x202F;9) and 10.031 +/&#x2212; 0.852% in females (black, <italic>p</italic>&#x202F;=&#x202F;0.078675, <italic>n</italic>&#x202F;=&#x202F;10). In L2KO males, the reduction in freezing was 4.149+/&#x2212; 0.788% (<italic>n</italic>&#x202F;=&#x202F;8), and in females, there was an increase in freezing of &#x2212;1.467 +/&#x2212; 0.910 (red, <italic>p</italic>&#x202F;=&#x202F;0.182, <italic>n</italic>&#x202F;=&#x202F;11). Y-axis is the reduction in percentage of time freezing during the test periods. <bold>(C)</bold> Extending extinction trials to 5&#x202F;days did not ameliorate the extinction deficit in <italic>Lynx2</italic>KO mice. When extending the number of extinction days from 2 to 5, WT mice (black line) display a reduction in percent freezing to tone/CS while <italic>Lynx2</italic>KO mice (red line) have an overall maintenance of fear. <italic>Lynx2</italic>KO mice continue to display elevated freezing during extinction across all days (&#x002A;&#x002A;&#x002A;<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001). <bold>(D)</bold> With a weaker training protocol to mitigate any differences in fear learning between WT and L2KO mice, there were no significantly different levels of freezing (%) on test day 1 (Ext 1), (<italic>p</italic>&#x202F;=&#x202F;0.542). By the second test day (Ext 2), the <italic>Lynx2</italic>KO mice (red line) still freeze more as compared to WT mice (black line), exhibiting a lack of fear extinction behavior (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001). WT <italic>n</italic>&#x202F;=&#x202F;10, L2KO <italic>n</italic>&#x202F;=&#x202F;10, Y-axis is percent freezing to tone (CS).</p>
</caption>
<graphic xlink:href="fnins-19-1466166-g001.tif"/>
</fig>
<p>Comparison of sex differences demonstrated comparable amounts of extinction in the WT (<italic>p</italic>&#x202F;=&#x202F;0.182) and <italic>Lynx2</italic>KO (<italic>p</italic>&#x202F;=&#x202F;0.183) groups (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), two-way ANOVA for gender genotype (<italic>n</italic>&#x202F;=&#x202F;46, <italic>p</italic>&#x202F;=&#x202F;0.511, F&#x202F;=&#x202F;0.743, <italic>p</italic>&#x202F;=&#x202F;0.395). These findings indicate that sex did not significantly influence the outcomes in this study, and the males and females were grouped. In the WT group, male extinguished fear 8.32 +/&#x2212;0.18% (black, <italic>p</italic>&#x202F;=&#x202F;0.078675, males <italic>n</italic>&#x202F;=&#x202F;9), whereas WT females reduced freezing 10.03 +/&#x2212; 0.85% (<italic>n</italic>&#x202F;=&#x202F;10). <italic>Lynx2</italic>KO males extinguished 4.149 +/&#x2212; 0.788%, and females increased their fear, extinguishing &#x2212;1.4672 +/&#x2212; 0.9105% (red, males <italic>n</italic>&#x202F;=&#x202F;8, females <italic>n</italic>&#x202F;=&#x202F;11).</p>
<p>We found that <italic>Lynx2</italic>KO mice displayed heightened fear responses and a lack of fear extinction, as demonstrated by a maintained level of freezing over the course of extinction trials. Fear extinction is an active process that results in the formation of a new memory in which the conditioned stimulus (CS) is no longer predictive of the unconditioned stimulus (US). We sought to distinguish between lack of ability to extinguish versus a delayed or reduced sensitivity, as it is possible the <italic>Lynx2</italic>KO mice need additional input to form a safety memory that can outcompete the original fear memory. To establish the strength and longevity of the abnormal response in the fear extinction paradigm of <italic>Lynx2</italic>KO mice, we extended the number of fear extinction sessions from 2&#x202F;days to 5&#x202F;days.</p>
<p>WT mice (black line) display a reduction in percent freezing to tone/CS over the 5 extinction days, while <italic>Lynx2</italic>KO mice (red line) demonstrate a maintenance of fear. Although <italic>Lynx2</italic>KO mice show a trend in inter-trial (within extinction day) extinction after several sound presentations, the reduction in freezing from day to day is not significant resulting in a lack of extinction behavior. A one-way repeated measures ANOVA was conducted to compare the effect of genotype on freezing during extinction day 1 through extinction day 5. There was a significant effect of genotype [<italic>p</italic>&#x202F;=&#x202F;0.006, Wilks&#x2019; Lambda&#x202F;=&#x202F;0.410, <italic>F</italic><sub>(4, 24)</sub>&#x202F;=&#x202F;4.654]. Five paired <italic>t</italic>-tests were used for <italic>post-hoc</italic> comparisons, and in each day, the <italic>Lynx2</italic>KO group demonstrated significantly greater freezing than the WT one (day 1 <italic>t</italic>(28)&#x202F;=&#x202F;50.919, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, day 2, <italic>t</italic>(28)&#x202F;=&#x202F;33.236, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, day 3, <italic>t</italic>(28)&#x202F;=&#x202F;28.178, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, day 4, <italic>t</italic>(28)&#x202F;=&#x202F;21.075, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, day 5, <italic>t</italic>(28)&#x202F;=&#x202F;20.199, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001 WT <italic>n</italic>&#x202F;=&#x202F;12, L2KO <italic>n</italic>&#x202F;=&#x202F;16. Day 5 95% CI: WT [53.230, 60.804], KO [67.828, 71.665], Cohen&#x2019;s d&#x202F;=&#x202F;1.089) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p>
<p>A possible confound in assessing extinction ability could be the heightened fear learning exhibited by <italic>Lynx2</italic>KO mice. To mitigate this, a milder training protocol used to establish the fear-based associative memory was implemented, using a single tone-shock pairing and reduced shock intensity. With this milder training protocol, there are no differences between groups in fear learning, as demonstrated by day 1 percent freezing to tone (CS). <italic>Lynx2</italic>KO mice (red line), however, continue to exhibit a lack of fear extinction behavior, whereas WT mice undergo fear extinction (black line). A one-way repeated measures ANOVA was conducted to compare the effect of genotype on freezing during extinction day 1 and extinction day 2. There was a significant effect of genotype [Wilks&#x2019; Lambda&#x202F;=&#x202F;0.706, <italic>F</italic><sub>(1, 17)</sub>&#x202F;=&#x202F;7.095, <italic>p</italic>&#x202F;=&#x202F;0.016]. Two paired <italic>t</italic>-tests were used for <italic>post-hoc</italic> comparisons. A first paired samples <italic>t</italic>-test indicated no significant effect of genotype on day 1 freezing [<italic>t</italic>(18)&#x202F;=&#x202F;31.983, <italic>p</italic>&#x202F;=&#x202F;0.542]. A second paired samples <italic>t</italic>-test indicated a significant effect of genotype on day 2 freezing (<italic>t</italic>(18)&#x202F;=&#x202F;24.055, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.01. WT <italic>n</italic>&#x202F;=&#x202F;10, L2KO <italic>n</italic>&#x202F;=&#x202F;10, WT 95% CI [44.074, 61.840], L2KO 95% CI [57.740, 67.904], Cohen&#x2019;s d&#x202F;=&#x202F;0.996) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p>
</sec>
<sec id="sec16">
<title>Pharmacological blockade of &#x03B1;7 nAChRs restores fear extinction in <italic>Lynx2</italic>KO mice</title>
<p>We hypothesized that the <italic>Lynx2</italic>KO phenotype was due to nAChR hyperactivity from our current understanding of the mechanism of action of <italic>Lynx2</italic> and family members such as <italic>Lynx1</italic> (<xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>; <xref ref-type="bibr" rid="ref34">Iba&#x00F1;ez-Tallon et al., 2002</xref>; <xref ref-type="bibr" rid="ref57">Miwa et al., 2006</xref>; <xref ref-type="bibr" rid="ref76">Sherafat et al., 2021</xref>; <xref ref-type="bibr" rid="ref60">Morishita et al., 2010</xref>). We tested the ability of nAChR pharmacological treatment to restore normal extinction behavior in <italic>Lynx2</italic> KO mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Injection of mecamylamine, a general nAChR pore blocker, prior to extinction testing rescued fear extinction behavior in the <italic>Lynx2</italic>KO mice (<italic>p</italic>&#x202F;=&#x202F;0.000413, unpaired Student&#x2019;s <italic>t</italic>-test). These doses of mecamylamine, 0.3, 1.0, and 2.5 mg/kg, have no effect on the WT mice in this paradigm. A one-way repeated measures ANOVA was conducted to compare the effect of the drug in <italic>Lynx2</italic>KO mice on extinction, demonstrating a significant effect of the drug [Wilks&#x2019; Lambda&#x202F;=&#x202F;0.750, <italic>F</italic><sub>(1, 56)</sub>&#x202F;=&#x202F;6.236, <italic>p</italic>&#x202F;=&#x202F;0.001]. Bonferroni <italic>post-hoc</italic> showed a significant effect at each mecamylamine dose; L2KO vs. L2KO 0.3&#x202F;mg/kg (M&#x202F;=&#x202F;&#x2212;7.154, SE&#x202F;=&#x202F;2.568) <italic>p</italic>&#x202F;=&#x202F;0.044, L2KO vs. L2KO 1&#x202F;mg/kg (M&#x202F;=&#x202F;11.337, SE&#x202F;=&#x202F;2.66) <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, L2KO saline <italic>n</italic>&#x202F;=&#x202F;20, L2KO 2.5&#x202F;mg/kg <italic>n</italic>&#x202F;=&#x202F;11, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, L2KO 1&#x202F;mg/kg <italic>n</italic>&#x202F;=&#x202F;14, L2KO 0.3&#x202F;mg/kg <italic>n</italic>&#x202F;=&#x202F;10. 95% CI, L2KO [69.536, 76.310], L2KO 2.5&#x202F;mg/kg [53.717, 69.934], L2KO 1&#x202F;mg/kg [47.831, 59.615], L2KO 0.3&#x202F;mg/kg [53.184, 65.183] (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption><p>Cholinergic blockade implicates distinct nAChRs in <italic>Lynx2</italic>-mediated behaviors <bold>(A)</bold> Blocking nAChR channels with mecamylamine rescues the lack of fear extinction in Lynx2KO mice, compared to <italic>Lynx2</italic>KO mice without mecamylamine at all doses tested (red line, <italic>p</italic>&#x202F;=&#x202F;0.001). Y-axis is percent of the time freezing to tone (CS). <bold>(B)</bold> Mecamylamine blockade of nAChRs does not have a significant effect in the WT mouse (<italic>p</italic>&#x202F;=&#x202F;1.057). Y-axis is percent of the time freezing to tone. <bold>(C)</bold> Antagonism of &#x03B1;7, but not DHBE, nAChRs rescues the fear extinction phenotype in <italic>Lynx2</italic> KO mice (red, <italic>p</italic>&#x202F;=&#x202F;0.0000186, two-way ANOVA). Blocking &#x03B1;7 nAChRs with MLA (1&#x202F;mg/kg) allowed <italic>Lynx2</italic> KO mice (red) to extinguish, as seen as a reduction in freezing behavior (<italic>p</italic>&#x202F;=&#x202F;0.000143). Each dot represents the difference in percent freezing (Ext 1 - Ext day 2) for a male (blue) or female (pink) mouse. A two-way ANOVA revealed that the difference in fear extinction among treated wild-type mice (black) was not statistically significant from naive wild-type mice. (<italic>p</italic>&#x202F;=&#x202F;0.79) Y-axis is the reduction of freezing from day 1 to day 2.</p>
</caption>
<graphic xlink:href="fnins-19-1466166-g002.tif"/>
</fig>
<p>Utilizing more specific nAChR antagonists, we found that MLA, an &#x03B1;7 antagonist, rescued the <italic>Lynx2</italic>KO fear extinction phenotype and demonstrated levels of extinction comparable to WT mice (naive <italic>n</italic>&#x202F;=&#x202F;19, treated <italic>n</italic>&#x202F;=&#x202F;14, <italic>p</italic>&#x202F;=&#x202F;0.000143, unpaired Student&#x2019;s <italic>t</italic>-test) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Dihydro-<italic>&#x03B2;</italic>-erythroidine (Dh&#x03B2;E), a heteromeric nAChR antagonist as opposed to the homomeric &#x03B1;7 nAChR subtype, did not alter extinction in <italic>Lynx2</italic>KO mice (naive <italic>n</italic>&#x202F;=&#x202F;19, treated <italic>n</italic>&#x202F;=&#x202F;6, <italic>p</italic>&#x202F;=&#x202F;0.4311) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), suggesting that the <italic>Lynx2</italic>-based extinction phenotype is mediated by &#x03B1;7 nAChRs [one-way ANOVA <italic>F</italic><sub>(7)</sub>&#x202F;=&#x202F;10.629, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001] (<xref ref-type="bibr" rid="ref19">Drasdo et al., 1992</xref>; <xref ref-type="bibr" rid="ref16">Damaj et al., 1995</xref>). A two-way ANOVA was conducted on these data, assessing extinction across sexes and genetic lines. This revealed that the difference in fear extinction among treated wild-type (black) mice was not statistically significant as compared to naive WT mice (<italic>p</italic>&#x202F;=&#x202F;0.79), whereas this effect was significant in <italic>Lynx2</italic>KO mice (red) (<italic>p</italic>&#x202F;=&#x202F;0.0000186) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). In addition, a Cohen&#x2019;s d-test was used to determine the effect size of these treatments on <italic>Lynx2</italic>KO mice. The effect size of mecamylamine was 1.15, the effect size of MLA was 1.22, and the effect size of Dh&#x03B2;E was 0.277.</p>
</sec>
<sec id="sec17">
<title>Abnormal response to chronic social defeat in <italic>Lynx2</italic>KO&#x2014;a nearly uniform resilience response</title>
<p>To investigate how an etiologically relevant stressor influences responses of mice predisposed to anxiety, we conducted chronic social defeat stress (CSDS) and assessed by a social interaction test. We first ran a control social interaction test, without a stress component, to confirm the abnormal sociability-like behavior of the <italic>Lynx2</italic>KO previously reported in (<xref ref-type="bibr" rid="ref80">Tekinay et al. (2009)</xref> and determine whether it had been maintained over the course of generations. In social interaction tests, a test mouse was added to an arena with a restrained conspecific stranger mouse which allowed for the flow of sensory information of the stranger without physical contact. The evaluation of the phenotype was conducted by generating an SI ratio of time spent in the interaction zone with the stranger mouse vs. when there was no stranger mouse present, using a cutoff of 1.5 (see Methods, data not shown). The naive <italic>Lynx2</italic>KO mice avoided the C57Bl6 stranger mouse to a greater degree than WT mice did. These observations were consistent with previous reports (<xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>), confirming the affective phenotype while allowing the CD1 mice to remain novel until the start of the CSDS sessions. (<xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>).</p>
<p>Having confirmed the social interaction phenotype was maintained in naive Lynx2KO mice, we conducted chronic social defeat stress (CSDS) on them. We performed 10 days of CSDS, entailing daily bouts of aggressive interactions with aggressive CD1 mice, with extended sensory contact between bouts. Following the 10th day, mice were singly housed for 1 day in a home cage before undergoing social interaction (SI) with a CD1 mouse as the stranger (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Measuring SI ratios following CSDS, the WT mice shift to lower values, whereas Lynx2KO mice demonstrate an increase in SI ratio, indicating an overall preference toward the stranger mouse (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Defeated WT test mice displayed the expected divergent stress responses of the population, with individuals displaying either the resilient/approach (blue) and susceptible/avoidant phenotypes (gray) (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). On the other hand, all the post-defeat KO mice displayed the resilient/approach phenotype&#x2014;a marked difference from pre-defeat scores, even with an SI ratio cutoff that increases the criteria for resiliency (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). There was no significant difference in the time spent in the interaction zone by the resilient subset of WT mice and the Lynx2KO mice. There were significant differences in the time spent in the interaction zone between the resilient mice and the susceptible WT mice (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Based upon social interaction ratios post-defeat, there are WT mice that approach and spend a greater percentage of time in the interaction zone (CSDS Resilient) as compared to WT mice that do not approach and spend less time in the interaction zone (CSDS Susceptible). Interestingly, there were no Lynx2KO mice that display a non-approach/susceptible phenotype. All Lynx2KO mice post-defeat spent a larger percentage of time in the interaction zone. One-Way ANOVA F = 14.016, <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, Bonferroni post-hoc: WT vs. L2KO <italic>p</italic>&#x202F;=&#x202F;0.019, WT vs. CSDS L2KO <italic>p</italic>&#x202F;=&#x202F;0.005, L2KO vs. CSDS KO <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, L2KO vs. CSDS WT Resilient p &#x003C; 0.001, CSDS WT Resilient vs. CSDS WT Susceptible p = 0.016, CSDS L2KO vs. CSDS WT Susceptible <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001. WT <italic>n</italic>&#x202F;=&#x202F;17, L2 KO <italic>n</italic>&#x202F;=&#x202F;17, CSDS L2KO <italic>n</italic>&#x202F;=&#x202F;17, CSDS WT Resilient <italic>n</italic>&#x202F;=&#x202F;10, CSDS WT Susceptible <italic>n</italic>&#x202F;=&#x202F;7. 95% CI: WT [27.383, 44.147], L2KO [12.504, 26.060], CSDS Resilient WT [24.782, 44.551], CSDS Susceptible WT [27.017, 43.841], CSDS Resilient L2KO [44.495, 61.701]. Cohen&#x2019;s d WT No CSDS vs. KO NO CSDS = 1.118, No CSDS L2KO vs. CSDS Approach L2KO = 1.927 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption><p>Shift in all social interaction behavior following CSDS in <italic>Lynx2</italic>KO mice. <bold>(A)</bold> Schematic of chronic social defeat stress timeline: Prior to CSDS, CD1 mice are screened for aggression. Mice undergo 10&#x202F;days of CSDS (chronic social defeat stress), entailing daily bouts of aggressive interactions with extended sensory contact. Following the 10th day, mice are singly housed for 1&#x202F;day before undergoing social interaction tests (SI). <bold>(B)</bold> After experiencing chronic social defeat stress, wild-type mice show a population split in social interaction phenotype between resilient (blue) and susceptible (gray) phenotypes in response to a CD1 mouse. All <italic>Lynx2</italic>KO mice, however, exhibit a population phenotype of resilient. <bold>(C)</bold> Prior to defeat, <italic>Lynx2</italic>KO mice display less time in the social interaction zone and exhibit social avoidance (No CSDS groups, <italic>p</italic>&#x202F;=&#x202F;0.019). Based upon social interaction ratios post-defeat, there are WT mice that approach and spend a greater percentage of time in the interaction zone (CSDS Resilient) as well as WT mice that do not approach and spend less time in the interaction zone (CSDS Susceptible). There are no Lynx2KO mice that display a non-approach/susceptible phenotype after defeat. All <italic>Lynx2</italic>KO mice post-defeat spend a larger percentage of time in the interaction zone after defeat (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001). Y-axis is percentage of the cohort, resilient (blue) susceptible (gray). <bold>(D)</bold> Social interaction ratios (SI) change in WT (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.001, <italic>n</italic>&#x202F;=&#x202F;17) and KO mice post-defeat (<italic>p</italic>&#x202F;=&#x202F;0.038, <italic>n</italic>&#x202F;=&#x202F;17). Y-axis is SI ratio.</p></caption>
<graphic xlink:href="fnins-19-1466166-g003.tif"/>
</fig>
<p>Nicotine has been shown to augment resilience in response to CSDS (<xref ref-type="bibr" rid="ref58">Khalifeh et al., 2020</xref>) and thus would be consistent with the nAChR hyperactivity that occurs due to <italic>Lynx2</italic> removal. The heightened basal anxiety in <italic>Lynx2</italic>KO mice could sensitize them to the defeat, in which case it might have been possible to detect both resilient and susceptible CSDS phenotypes in the KO cohort if given a reduced amount of defeat stress. Alternatively, the <italic>Lynx2</italic>KO mice could exhibit an exaggerated stress response that predisposes them to adopt a uniformly resilient phenotype independent of the amount of defeat stress. This may be analogous to the effects seen in fear extinction experiments in which the <italic>Lynx2</italic>KO mice failed to extinguish their fear, even with a lower training stimuli or an extended number of extinction days. To adapt to any potential hypersensitivity or responsiveness of <italic>Lynx2</italic>KO mice, we asked whether, by lowering the amount of stress given, some of the <italic>Lynx2</italic>KO mice would adopt a susceptible phenotype. We modified the CSDS paradigm by reducing the number of defeat days from 10 to 3, in an attempt to lower the degree of stress while retaining many of the critical features of the validated CSDS paradigm (<xref ref-type="bibr" rid="ref18">Donahue et al., 2015</xref>; <xref ref-type="bibr" rid="ref66">Pagliusi and Sartori, 2019</xref>; <xref ref-type="bibr" rid="ref71">Qi et al., 2022</xref>). In this experiment, which we refer to here as acute defeat stress, mice were subjected to three trials per day on three consecutive days. In this 3-day modified CSDS paradigm, the <italic>Lynx2</italic>KO mice continued to display a resilient phenotype 100% of the time. WT mice display a divergent response including both resilience/approach and susceptible (<xref ref-type="fig" rid="fig4">Figure 4A</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption><p><bold>(A)</bold> In a 3-day acute social defeat stress paradigm, the WT and <italic>Lynx2</italic>KO mice continue to display the same trends of the 10-day CSDS paradigm: WT mice display a divergent response, while the <italic>Lynx2</italic>KO mice display one population response, resilience/approach. The double knockout restores the population response to that of WT levels with instances of both the susceptible and resilient phenotypes. <bold>(B)</bold> The &#x03B1;7/Lynx2 double knockout (green line) with a deletion of both the &#x03B1;7 nAChR and <italic>Lynx2</italic> genes restores fear extinction behavior to that of WT levels (black line) as compared to <italic>Lynx2</italic>KO mice (red line). A one-way repeated measures ANOVA was conducted to compare the effect of genotype on freezing during extinction day 1 and extinction day 2. There was a significant effect of the genotype on freezing; Wilks&#x2019; Lambda&#x202F;=&#x202F;0.836 [<italic>F</italic><sub>(1, 49)</sub>&#x202F;=&#x202F;4.793, <italic>p</italic>&#x202F;=&#x202F;0.013]. Bonferroni <italic>post-hoc</italic>: WT vs. L2KO (M&#x202F;=&#x202F;9.6752, SE&#x202F;=&#x202F;3.095) <italic>p</italic>&#x202F;=&#x202F;0.009, WT vs. &#x03B1;7L2 (M&#x202F;=&#x202F;4.4857, SE&#x202F;=&#x202F;3.22) <italic>p</italic>&#x202F;=&#x202F;0.513, L2KO vs. &#x03B1;7L2KO (M&#x202F;=&#x202F;8.3485, SE&#x202F;=&#x202F;3.14) <italic>p</italic>&#x202F;=&#x202F;0.032. WT <italic>n</italic>&#x202F;=&#x202F;16, L2K <italic>n</italic>&#x202F;=&#x202F;20, &#x03B1;7L2 <italic>n</italic>&#x202F;=&#x202F;16. 95% CI: WT [51.548, 64.244], L2KO [69.536, 76.310], &#x03B1;7L2 [58.846, 69.045]. Cohen&#x2019;s d L2KO vs. &#x03B1;7L2&#x202F;=&#x202F;1.050. <bold>(C)</bold> Western blot analyses showing the results of co-immunoprecipitation experiments. <italic>Lynx2</italic>KO was immunoprecipitated from homogenates of mouse amygdalae using an anti-<italic>Lynx2</italic>KO antibody. Then, a Western blot was run on these samples using anti-&#x03B1;7 nAChR antibodies (52 kd). These bands allow us to observe the stable complex of LYNX2 and the &#x03B1;7 nAChR subunit in the brain. WT animals are from different animals either of C57bl6 mice (WT 1-4) or WT littermates of the B2 nAChR-GFP mouse line (WT 5-7). WT 3 is from whole brain extract of a C57bl6 mouse, demonstrating enrichment of this complex in the amygdala. The amygdalae extracts of <italic>Lynx2</italic>KO mice were immunoprecipitated as controls (one shown here), Note that no bands are present in the <italic>Lynx2</italic>KO samples, indicating the specificity of the interaction.</p></caption>
<graphic xlink:href="fnins-19-1466166-g004.tif"/>
</fig>
</sec>
<sec id="sec18">
<title>Genetic rescue of both fear extinction and social defeat stress in <italic>Lynx2</italic>KO mice via &#x03B1;7 nAChRs removal</title>
<p>&#x03B1;7 nAChRs have been shown to be one nAChR subtype targeted by the LYNX2 protein, although other nAChR subtypes have been shown to bind to LYNX2 (<xref ref-type="bibr" rid="ref70">Pisapati et al., 2021</xref>; <xref ref-type="bibr" rid="ref84">Wu et al., 2015</xref>; <xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>). To confirm the pharmacological studies implicating &#x03B1;7 nAChRs in the fear extinction phenotype of <italic>Lynx2</italic>KO mice, we sought a genetic confirmation of &#x03B1;7 nAChRs involvement. The <italic>Lynx2</italic>KO mouse line was crossed to an &#x03B1;7 nAChR null mutant line (&#x03B1;7KO), to generate an independent <italic>Lynx2</italic>/&#x03B1;7 nAChR double KO line, and was tested using the fear extinction paradigm. The <italic>Lynx2</italic>/&#x03B1;7 nAChR double KO line was observed to extinguish to a similar degree as WT vs. <italic>Lynx2</italic>KO (<italic>p</italic>&#x202F;=&#x202F;0.009), WT vs. <italic>Lynx2</italic>/&#x03B1;7 (<italic>p</italic>&#x202F;=&#x202F;0.513), <italic>Lynx2</italic>KO vs. <italic>Lynx2</italic>/&#x03B1;7 (<italic>p</italic>&#x202F;=&#x202F;0.032), rescuing the <italic>Lynx2</italic>KO phenotype, adding to the evidence that Lynx2-based extinction is &#x03B1;7-mediated. A one-way repeated measures ANOVA was conducted to compare the effect of genotype on freezing during extinction day 1 and extinction day 2. There was a significant effect of genotype on freezing; Wilks&#x2019; Lambda&#x202F;=&#x202F;0.836 [<italic>F</italic><sub>(1, 49)</sub>&#x202F;=&#x202F;4.793, <italic>p</italic>&#x202F;=&#x202F;0.013]. Bonferroni <italic>post-hoc</italic>: WT vs. L2 KO (M&#x202F;=&#x202F;9.6752, SE&#x202F;=&#x202F;3.095) <italic>p</italic>&#x202F;=&#x202F;0.009, WT vs. &#x03B1;7L2 (M&#x202F;=&#x202F;4.4857, SE&#x202F;=&#x202F;3.22) <italic>p</italic>&#x202F;=&#x202F;0.513, L2KO vs. &#x03B1;7L2KO (M&#x202F;=&#x202F;8.3485, SE&#x202F;=&#x202F;3.14) <italic>p</italic>&#x202F;=&#x202F;0.032&#x002A;. WT <italic>n</italic>&#x202F;=&#x202F;16, L2KO <italic>n</italic>&#x202F;=&#x202F;20, &#x03B1;7L2 <italic>n</italic>&#x202F;=&#x202F;16. 95% CI: WT [51.548, 64.244], L2KO [69.536, 76.310], &#x03B1;7L2 [58.846, 69.045]. Cohen&#x2019;s d L2KO vs. &#x03B1;7L2&#x202F;=&#x202F;1.050 (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). The effect size of this genetic modification was calculated as a reduction in percent freezing, in a Cohen&#x2019;s d-test between the <italic>Lynx2</italic>KO and &#x03B1;7KO/<italic>Lynx2</italic> double KO lines. Within WT mice, we analyzed differences between males and females in line with reported observations for sex differences in fear extinction of WT mice (<xref ref-type="bibr" rid="ref12">Clark et al., 2019</xref>). Within the entire dataset, we found a significant difference of genotype (ANOVA, <italic>p</italic>&#x202F;=&#x202F;0.000799) and sex (<italic>p</italic>&#x202F;=&#x202F;0.0248) but not in the sex &#x00D7; genotype interaction (<italic>p</italic>&#x202F;=&#x202F;0.104). Sex differences were found in the WT group, but they were not found in the <italic>Lynx2</italic>KO or Lynx2/&#x03B1;7KO double KO groups. Male WT mice reduced freezing more than that of female WT mice (<italic>p</italic>&#x202F;=&#x202F;0.01, male <italic>n</italic>&#x202F;=&#x202F;10, female <italic>n</italic>&#x202F;=&#x202F;13), contrasted with the <italic>Lynx2</italic> KO (<italic>p</italic>&#x202F;=&#x202F;0.182) or <italic>Lynx2</italic>/&#x03B1;7 dKO groups (<italic>p</italic>&#x202F;=&#x202F;0.267) (graph not shown).</p>
<p>We tested the Lynx2/&#x03B1;7KO double KO double knockout line in the 3-day acute defeat protocol. The &#x03B1;7/<italic>Lynx2</italic> double knockout mice displayed divergent stress responses of both susceptible and resilient phenotypes, to the same proportion as that of WT mice (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), demonstrating that &#x03B1;7 nAChRs mediate these abnormal responses in <italic>Lynx2</italic>KO mice. These data support the involvement of <italic>Lynx2</italic> and &#x03B1;7 nAChRs in both fear extinction and acute social defeat paradigms.</p>
</sec>
<sec id="sec19">
<title>Physical interaction of LYNX2 and &#x03B1;7 naChRs in the amygdala</title>
<p>A LYNX2 protein-nAChR complex has never been detected <italic>in vivo</italic> but is a critical piece of information to interpret the functional relevance of the pharmacological and genetic results. To establish the physical interaction of LYNX2 and &#x03B1;7 nAChR proteins, co-immunoprecipitation experiments were performed to isolate LYNX2-nAChR stable complexes in the mouse brain. To detect specific components of the complex, we immunoprecipitated the LYNX2 protein from homogenates of the mouse amygdala using an anti-LYNX (LYPD1) antibody and performed Western blot analyses to detect the presence of &#x03B1;7 nAChRs using an anti-&#x03B1;7 nAChR antibody. Precipitated LYNX2-containing complexes from extracts of WT brain samples yielded a band corresponding to the &#x03B1;7 nAChRs subunit, providing evidence that LYNX2 forms a stable complex with &#x03B1;7 nAChRs in the mammalian brain (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). No bands were seen in control samples prepared from <italic>Lynx2</italic>KO mice, indicating the specificity of the interaction. Taken together, our results indicate the role of <italic>Lynx2</italic> modulation of &#x03B1;7 nAChRs in the abnormal fear extinction and responses to social defeat stress.</p>
</sec>
<sec id="sec20">
<title>Defeat causes changes in <italic>Lynx2</italic>KO BDNF levels in the VTA</title>
<p>BDNF levels in the ventral tegmental area (VTA) have been shown to increase after CSDS in susceptible animals and to play a role in behavioral responses to CSDS (<xref ref-type="bibr" rid="ref41">Koo Wook et al., 2016</xref>; <xref ref-type="bibr" rid="ref40">Koo et al., 2019</xref>). We hypothesized that abnormalities in VTA BDNF levels might be a factor in the resilient phenotype seen in the <italic>Lynx2</italic>KO mice. We isolated the VTA from defeated mice and performed Western blots using an anti-BDNF antibody and quantitated the band intensity using Image J. There was a decreased BDNF level in <italic>Lynx2</italic>KO mice relative to WT controls, in both the naive and CDSD mice (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Compared to naive levels, there was an increase following defeat in both the groups but was more pronounced in the WT than in the <italic>Lynx2</italic>KO mice. Quantitation was obtained by measuring the intensity of BDNF normalized to actin of that lane, measured using ImageJ software (B2 CSDS M&#x202F;=&#x202F;0.6213, SE&#x202F;=&#x202F;0.0748; B2 control M&#x202F;=&#x202F;&#x2212;0.0553, SE&#x202F;=&#x202F;0.0949; <italic>Lynx2</italic> CSDS M&#x202F;=&#x202F;0.1177, SE&#x202F;=&#x202F;0.0461; <italic>Lynx2</italic> control M&#x202F;=&#x202F;&#x2212;0.0477, SE&#x202F;=&#x202F;0.0837. B2 CSDS vs. <italic>Lynx2</italic> CSDS <italic>p</italic>&#x202F;=&#x202F;0.0149) (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). The bands were found to have molecular weights of approximately 41&#x202F;kDa and 28&#x202F;kDa, corresponding to the expected values for actin and BDNF, respectively (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). These data are consistent with the role of VTA BDNF in susceptibility.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption><p><bold>(A)</bold> BDNF levels in the VTA respond to the effects of CSDS: Western blot using anti-BDNF and actin antibodies showing the presence of BDNF in mouse VTA. <bold>(B)</bold> Quantitation of VTA BDNF levels: The relative intensities of the BDNF bands were normalized to actin, demonstrating a significant difference in BDNF protein between WT and <italic>Lynx2</italic>KO VTAs (<italic>p</italic>&#x202F;=&#x202F;0.0149), measured using ImageJ software. The BDNF levels were significantly lowered after CSDS in WT. BDNF levels in the <italic>Lynx2</italic>KO VTAs did not change significantly. <bold>(C)</bold> The molecular weight of sample bands was determined by plotting the distance traveled by the standards against the log of their known molecular weight. A line of best fit was generated, and bands were fit to that line according to their rf. Bands were determined to have the molecular weight of approximately 41 and 28, corresponding to the expected values of actin and BDNF.</p></caption>
<graphic xlink:href="fnins-19-1466166-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec21">
<title>Discussion</title>
<p><italic>Lynx2</italic> removal has been shown to lead to nAChR hyperactivity and heightened basal anxiety-like behavior (<xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>). In this context, here we explored how augmented anxiety-like behavior may influence adaptive behaviors involving more specific threats. We found that <italic>Lynx2</italic>KO mice were unable to extinguish conditioned fear in extinction assays and showed a marked uniform resilience response in acute and chronic defeat stress. Fear extinction could be ameliorated through pharmacological blockade of &#x03B1;7 nAChRs, and in addition, fear extinction and acute social defeat could be restored through genetic perturbations of &#x03B1;7 nAChRs. Together with biochemical studies indicating a stable direct interaction of LYNX2 and &#x03B1;7 nAChRs in the amygdala, these data indicate that LYNX2 plays a regulatory role in &#x03B1;7 nAChR function for moderating fear extinction and responses to social defeat stress. Basal anxiety-like behavior in mice is thought to mirror trait anxiety in humans (<xref ref-type="bibr" rid="ref62">O&#x2019;Leary et al., 2013</xref>). There is a close relationship between trait anxiety, a person&#x2019;s predisposition toward anxiety, and state anxiety, their reaction to specific cues or during specific events (<xref ref-type="bibr" rid="ref72">Ree et al., 2008</xref>). Hence, it would be expected that a mouse model of elevated basal anxiety-like behavior may also have abnormalities in other fear and anxiety-like processes.</p>
<p>The cholinergic system is recognized as an important regulator of affective health (<xref ref-type="bibr" rid="ref55">Mineur et al., 2016</xref>). There are optimal levels of ACh that can be beneficial, while excessive cholinergic signaling can be detrimental and lead to affective disorders. The cholinergic system is involved in both acquisition and extinction of fear memories (<xref ref-type="bibr" rid="ref45">Kutlu and Gould, 2015</xref>), and acetylcholine is released to the auditory cortex in response to shock to promote fear learning (<xref ref-type="bibr" rid="ref42">Krabbe et al., 2018</xref>). Extinction of learned fear involves plasticity mechanisms and the formation of new safety memories (<xref ref-type="bibr" rid="ref28">Hasco&#x00EB;t et al., 2001</xref>; <xref ref-type="bibr" rid="ref37">Jiang et al., 2016</xref>; <xref ref-type="bibr" rid="ref39">Kim et al., 2007</xref>; <xref ref-type="bibr" rid="ref15">Dalton et al., 2012</xref>; <xref ref-type="bibr" rid="ref50">Maren, 2015</xref>; <xref ref-type="bibr" rid="ref74">Saha et al., 2017</xref>; <xref ref-type="bibr" rid="ref86">Zhu et al., 2017</xref>) and includes, among other mechanisms, long-term depression of connections involved in the conditioned fear association, through activation of pathways coming from the medial prefrontal cortex to the amygdalar region (<xref ref-type="bibr" rid="ref10">Cho et al., 2013</xref>; <xref ref-type="bibr" rid="ref24">Gilman et al., 2018</xref>). mEPSCs frequency has been shown to be elevated in the prefrontal cortex of <italic>Lynx2</italic>KO mice in response to nicotine (<xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>), and it would be interesting to test whether abnormalities in long-term depression are operating in <italic>Lynx2</italic>KO mice. Alterations in calcium levels by LYNX2 have been reported <italic>in vitro</italic> (<xref ref-type="bibr" rid="ref84">Wu et al., 2015</xref>). Nicotinic receptor activation has been associated with lack of fear extinction (<xref ref-type="bibr" rid="ref44">Kutlu and Gould, 2014</xref>), and optogenetic activation of cholinergic afferents from the medial prefrontal cortex into the amygdala can retard fear extinction, while optogenetic inhibition accelerates it (<xref ref-type="bibr" rid="ref37">Jiang et al., 2016</xref>). The final output of fear comes from the central amygdala which integrates multiple inputs such as the prefrontal cortex. As such, increases in amygdala cholinergic tone may serve to weigh the balance in favor of maintenance of fear (<xref ref-type="bibr" rid="ref37">Jiang et al., 2016</xref>). <italic>Lynx2</italic> is expressed in the prefrontal cortex and amygdala, among many other brain regions, so it is not possible to know to what degree each might contribute to the extinction phenotype (<xref ref-type="bibr" rid="ref80">Tekinay et al., 2009</xref>; <xref ref-type="bibr" rid="ref76">Sherafat et al., 2021</xref>). A regulatory mechanism such as LYNX2 that can dampen nAChR responsiveness may be one such control mechanism that allows the individual to appropriately update conditioned fears.</p>
<p>Our data point to a regulatory role of &#x03B1;7-containing nAChRs within key circuits underlying social defeat as well, in line with reports tying the nicotinic receptor system to modulation of social defeat (<xref ref-type="bibr" rid="ref64">Ortiz et al., 2022</xref>; <xref ref-type="bibr" rid="ref58">Khalifeh et al., 2020</xref>). A relationship between responses to social defeat stress and fear extinction has been demonstrated previously, when the WT subgroup that displayed the resilient/approach response to acute social defeat also displayed a lack of fear extinction (<xref ref-type="bibr" rid="ref54">Meduri et al., 2013</xref>). In line with this profile, <italic>Lynx2</italic>KO mice exhibit an extreme form of this relationship, a marked lack of fear extinction and a uniform resiliency/approach following CSDS (<xref ref-type="bibr" rid="ref36">Jasnow et al., 2004</xref>; <xref ref-type="bibr" rid="ref35">Jasnow et al., 2005</xref>), likely a consequence of unbalanced nicotinic receptor activity.</p>
<p>A resilient social defeat stress response has been demonstrated in nicotine exposed animals (<xref ref-type="bibr" rid="ref58">Khalifeh et al., 2020</xref>), inducing brain-derived neurotrophic factor (BDNF), a trophic protein implicated in many neuroplasticity processes (<xref ref-type="bibr" rid="ref49">Mallei et al., 2019</xref>; <xref ref-type="bibr" rid="ref58">Khalifeh et al., 2020</xref>; <xref ref-type="bibr" rid="ref11">Chou et al., 2014</xref>; <xref ref-type="bibr" rid="ref59">Monkol et al., 2016</xref>). Other work has linked increased BDNF in the VTA to susceptible defeat outcomes (<xref ref-type="bibr" rid="ref41">Koo Wook et al., 2016</xref>). Social defeat stress has been shown to be altered by dopaminergic activity in susceptible mice (<xref ref-type="bibr" rid="ref85">Zhao et al., 2021</xref>; <xref ref-type="bibr" rid="ref61">Numa et al., 2019</xref>; <xref ref-type="bibr" rid="ref43">Krishnan et al., 2007</xref>) and to mediate mPFC activity radiating into the amygdala (<xref ref-type="bibr" rid="ref61">Numa et al., 2019</xref>). It is unknown if increases in excitability that induce BDNF are altered in these or other brain regions of the <italic>Lynx2</italic>KO mouse due to activity-dependent acetylcholine release (<xref ref-type="bibr" rid="ref1">Acquas et al., 1996</xref>; <xref ref-type="bibr" rid="ref47">Letzkus et al., 2011</xref>). In our studies, &#x03B1;7 nAChRs have been implicated in the tests performed here, but it should be noted that the &#x03B1;7/<italic>Lynx2</italic> DKO was tested with the 3-day acute defeat stress paradigm and was not tested in the standard 10-day CSDS one, so the direct test of &#x03B1;7 subtypes in CSDS is still an open question. Lower baseline levels of VTA BDNF or reduced BDNF induction in response to social defeat stress may explain, in part, the resilient phenotype of <italic>Lynx2</italic>KO mice. The reduction in BDNF levels post-defeat was more substantial in WT mice, but given the low starting levels of BDNF in naive mice, the modest reduction of BDNF in the <italic>Lynx2</italic>KO VTAs might be due to a floor effect. These data are consistent with the reported role of VTA BDNF in susceptibility (<xref ref-type="bibr" rid="ref47">Letzkus et al., 2011</xref>), although more work on this line needs to be done to clarify the relationship further.</p>
<p>We have focused this study on the relationship of basal anxiety to other anxiety-mediated behaviors. Because of expression of <italic>Lynx2</italic> in multiple brain regions, however, the phenotype of <italic>Lynx2</italic>KO mice is not confined to anxiety-like behavior. Interestingly, male <italic>Lynx2</italic>KO mice have been shown to have reduced acoustic startle response (<xref ref-type="bibr" rid="ref76">Sherafat et al., 2021</xref>). Elevations in the startle response have been correlated with higher anxiety (<xref ref-type="bibr" rid="ref68">Pantoni et al., 2020</xref>), so the reductions in acoustic startle in male <italic>Lynx2</italic>KO mice are not likely due to their increased basal anxiety-like behavior. The neural circuitry for acoustic startle response only partially overlaps that of basal anxiety, illustrating effects of <italic>Lynx2</italic> outside of the regions we have explored here.</p>
<p>In humans, individuals vary in their responses to social stress and later vulnerability to psychiatric disorders (<xref ref-type="bibr" rid="ref9">Charney and Manji, 2004</xref>; <xref ref-type="bibr" rid="ref43">Krishnan et al., 2007</xref>). Defining the biological factors that underlie predispositions toward anxiety and how environmental stressors act to modify these biological factors can aid in the development of effective therapies. Our results are not inconsistent with studies linking variation in the human LYNX2 gene with heightened levels of anxiety in humans (<xref ref-type="bibr" rid="ref4">Anderson et al., 2024</xref>). The <italic>Lynx2</italic>KO mouse model adds to the framework that nicotinic receptors may be an important factor in understanding affective disorders. Genetic factors which predispose an individual to heightened basal anxiety-like behavior could impair appropriate responses to more specific stressors. These results have implications for the treatment of inextinguishable anxiety and fear, such as that in generalized anxiety disorders, post-traumatic stress disorder, phobias, and other severe disorders.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec22">
<title>Data availability statement</title>
<p>Data available on request to authors.</p>
</sec>
<sec sec-type="ethics-statement" id="sec23">
<title>Ethics statement</title>
<p>The animal study was approved by Ethical approval to report this case series was obtained from Lehigh University&#x2019;s Ethics Committee. Ethical approval to report this case series was obtained from Institutional Animal Care and Usage Committee (IACUC) (approval ID# 147). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec24">
<title>Author contributions</title>
<p>KA: Conceptualization, Data curation, Formal Analysis, Methodology, Project administration, Supervision, Validation, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. PR: Data curation, Formal Analysis, Methodology, Validation, Writing &#x2013; review &#x0026; editing. TP: Data curation, Formal Analysis, Validation, Writing &#x2013; review &#x0026; editing, Methodology. JM: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec25">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by NIH NIDA R01DA043567, R21DA033831, NIH/GM GM123131, Det Frie Forskningsr&#x00E5;d CU-29979812, PA CURE 4100068719, Lehigh University (PJR), Nemes Fellowship (KRA), Sigma Xi (KRA), BDSI/HHMI, Mountaintop Project and the Office of Creative Inquiry.</p>
</sec>
<ack>
<p>We thank Marina Picciotto for her insights and critical reading of the manuscript and Katie Hoffman for helpful discussions. The Biological Sciences department at Lehigh University, Akeive Burrows, David Geyer, Juliana Orejuela, Solomaya Schwab, Jeff Paynter, and Neel Nissen.</p>
</ack>
<sec sec-type="COI-statement" id="sec26">
<title>Conflict of interest</title>
<p>JMM is the founder and holds shares in Ophidion, Inc., a biotechnology company.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec27">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acquas</surname> <given-names>E.</given-names></name> <name><surname>Wilson</surname> <given-names>C.</given-names></name> <name><surname>Fibiger</surname> <given-names>H. C.</given-names></name></person-group> (<year>1996</year>). <article-title>Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear</article-title>. <source>J. Neurosci.</source> <volume>16</volume>, <fpage>3089</fpage>&#x2013;<lpage>3096</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-09-03089.1996</pub-id>, PMID: <pub-id pub-id-type="pmid">8622138</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anacker</surname> <given-names>C.</given-names></name> <name><surname>Scholz</surname> <given-names>J.</given-names></name> <name><surname>O&#x2019;Donnell</surname> <given-names>K. J.</given-names></name> <name><surname>Allemang-Grand</surname> <given-names>R.</given-names></name> <name><surname>Diorio</surname> <given-names>J.</given-names></name> <name><surname>Bagot</surname> <given-names>R. C.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Neuroanatomic differences associated with stress susceptibility and resilience</article-title>. <source>Biol. Psychiatry</source> <volume>79</volume>, <fpage>840</fpage>&#x2013;<lpage>849</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.08.009</pub-id>, PMID: <pub-id pub-id-type="pmid">26422005</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>D. J.</given-names></name> <name><surname>Adolphs</surname> <given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>A framework for studying emotions across species</article-title>. <source>Cell</source> <volume>157</volume>, <fpage>187</fpage>&#x2013;<lpage>200</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2014.03.003</pub-id>, PMID: <pub-id pub-id-type="pmid">24679535</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>K. R.</given-names></name> <name><surname>Cao</surname> <given-names>W.</given-names></name> <name><surname>Lee</surname> <given-names>H. S.</given-names></name> <name><surname>Crenshaw</surname> <given-names>M. A.</given-names></name> <name><surname>Palumbo</surname> <given-names>T. B.</given-names></name> <name><surname>Fisher-Perez</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>A novel anxiety-associated SNP identified in LYNX2 (LYPD1) is associated with decreased protein binding to nicotinic acetylcholine receptors</article-title>. <source>Front. Behav. Neurosci.</source> <volume>18</volume>:<fpage>1347543</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2024.1347543</pub-id>, PMID: <pub-id pub-id-type="pmid">39763615</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagot</surname> <given-names>R. C.</given-names></name> <name><surname>Cates</surname> <given-names>H. M.</given-names></name> <name><surname>Purushothaman</surname> <given-names>I.</given-names></name> <name><surname>Lorsch</surname> <given-names>Z. S.</given-names></name> <name><surname>Walker</surname> <given-names>D. M.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Circuit-wide transcriptional profiling reveals brain region-specific gene networks regulating depression susceptibility</article-title>. <source>Neuron</source> <volume>90</volume>, <fpage>969</fpage>&#x2013;<lpage>983</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.015</pub-id>, PMID: <pub-id pub-id-type="pmid">27181059</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berton</surname> <given-names>O.</given-names></name> <name><surname>McClung</surname> <given-names>C. A.</given-names></name> <name><surname>Dileone</surname> <given-names>R. J.</given-names></name> <name><surname>Krishnan</surname> <given-names>V.</given-names></name> <name><surname>Renthal</surname> <given-names>W.</given-names></name> <name><surname>Russo</surname> <given-names>S. J.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress</article-title>. <source>Science</source> <volume>311</volume>, <fpage>864</fpage>&#x2013;<lpage>868</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1120972</pub-id>, PMID: <pub-id pub-id-type="pmid">16469931</pub-id></citation></ref>
<ref id="ref0070"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bouton</surname> <given-names>M. E.</given-names></name> <name><surname>Maren</surname> <given-names>S.</given-names></name> <name><surname>McNally</surname> <given-names>G. P</given-names></name></person-group>. (<year>2021</year>). <article-title>Behavioral and neurobiological mechanisms of pavlovian and instrumental extinction learning</article-title>.</citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calhoon</surname> <given-names>G. G.</given-names></name> <name><surname>Tye</surname> <given-names>K. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Resolving the neural circuits of anxiety</article-title>. <source>Nat. Neurosci.</source> <volume>18</volume>, <fpage>1394</fpage>&#x2013;<lpage>1404</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nn.4101</pub-id>, PMID: <pub-id pub-id-type="pmid">26404714</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname> <given-names>J.</given-names></name> <name><surname>Covington</surname> <given-names>H. E.</given-names></name> <name><surname>Friedman</surname> <given-names>A. K.</given-names></name> <name><surname>Wilkinson</surname> <given-names>M. B.</given-names></name> <name><surname>Walsh</surname> <given-names>J. J.</given-names></name> <name><surname>Cooper</surname> <given-names>D. C.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action</article-title>. <source>J. Neurosci.</source> <volume>30</volume>, <fpage>16453</fpage>&#x2013;<lpage>16458</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3177-10.2010</pub-id>, PMID: <pub-id pub-id-type="pmid">21147984</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Charney</surname> <given-names>D. S.</given-names></name> <name><surname>Manji</surname> <given-names>H. K.</given-names></name></person-group> (<year>2004</year>). <article-title>Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention</article-title>. <source>Sci. STKE</source> <volume>2004</volume>:<fpage>re5</fpage>. doi: <pub-id pub-id-type="doi">10.1126/stke.2252004re5</pub-id>, PMID: <pub-id pub-id-type="pmid">15039492</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>J. H.</given-names></name> <name><surname>Deisseroth</surname> <given-names>K.</given-names></name> <name><surname>Bolshakov</surname> <given-names>V. Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Synaptic encoding of fear extinction in mPFC-amygdala circuits</article-title>. <source>Neuron</source> <volume>80</volume>, <fpage>1491</fpage>&#x2013;<lpage>1507</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2013.09.025</pub-id>, PMID: <pub-id pub-id-type="pmid">24290204</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname> <given-names>D.</given-names></name> <name><surname>Huang</surname> <given-names>C. C.</given-names></name> <name><surname>Hsu</surname> <given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>Brain-derived neurotrophic factor in the amygdala mediates susceptibility to fear conditioning</article-title>. <source>Exp. Neurol.</source> <volume>255</volume>, <fpage>19</fpage>&#x2013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.expneurol.2014.02.016</pub-id>, PMID: <pub-id pub-id-type="pmid">24582917</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>J. W.</given-names></name> <name><surname>Drummond</surname> <given-names>S. P. A.</given-names></name> <name><surname>Hoyer</surname> <given-names>D.</given-names></name> <name><surname>Jacobson</surname> <given-names>L. H.</given-names></name></person-group> (<year>2019</year>). <article-title>Sex differences in mouse models of fear inhibition: fear extinction, safety learning, and fear-safety discrimination</article-title>. <source>Br. J. Pharmacol.</source> <volume>176</volume>, <fpage>4149</fpage>&#x2013;<lpage>4158</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bph.14600</pub-id>, PMID: <pub-id pub-id-type="pmid">30710446</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Craske</surname> <given-names>M. G.</given-names></name> <name><surname>Treanor</surname> <given-names>M.</given-names></name> <name><surname>Conway</surname> <given-names>C. C.</given-names></name> <name><surname>Zbozinek</surname> <given-names>T.</given-names></name> <name><surname>Vervliet</surname> <given-names>B.</given-names></name></person-group> (<year>2014</year>). <article-title>Maximizing exposure therapy: an inhibitory learning approach</article-title>. <source>Behav. Res. Ther.</source> <volume>58</volume>, <fpage>10</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brat.2014.04.006</pub-id>, PMID: <pub-id pub-id-type="pmid">24864005</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crimmins</surname> <given-names>B. E.</given-names></name> <name><surname>Lingawi</surname> <given-names>N. W.</given-names></name> <name><surname>Chieng</surname> <given-names>B. C.</given-names></name> <name><surname>Leung</surname> <given-names>B. K.</given-names></name> <name><surname>Maren</surname> <given-names>S.</given-names></name> <name><surname>Laurent</surname> <given-names>V.</given-names></name></person-group> (<year>2023</year>). <article-title>Basal forebrain cholinergic signaling in the basolateral amygdala promotes strength and durability of fear memories</article-title>. <source>Neuropsychopharmacology</source> <volume>48</volume>, <fpage>605</fpage>&#x2013;<lpage>614</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41386-022-01427-w</pub-id>, PMID: <pub-id pub-id-type="pmid">36056107</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname> <given-names>G. L.</given-names></name> <name><surname>Chuan</surname> <given-names>D.</given-names></name> <name><surname>Yu</surname> <given-names>T.</given-names></name> <name><surname>Wang</surname> <given-names>Y. T.</given-names></name> <name><surname>Florescobc</surname> <given-names>S. B.</given-names></name> <name><surname>Phillips</surname> <given-names>A. G.</given-names></name></person-group> (<year>2012</year>). <article-title>NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear</article-title>. <source>Neuropharmacology</source> <volume>62</volume>, <fpage>797</fpage>&#x2013;<lpage>806</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuropharm.2011.09.001</pub-id>, PMID: <pub-id pub-id-type="pmid">21925518</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damaj</surname> <given-names>M. I.</given-names></name> <name><surname>Welch</surname> <given-names>S. P.</given-names></name> <name><surname>Martin</surname> <given-names>B. R.</given-names></name></person-group> (<year>1995</year>). <article-title>In vivo pharmacological effects of dihydro-beta-erythroidine, a nicotinic antagonist, in mice</article-title>. <source>Psychopharmacology</source> <volume>117</volume>, <fpage>67</fpage>&#x2013;<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1007/BF02245100</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dessaud</surname> <given-names>E.</given-names></name> <name><surname>Sala&#x00FC;n</surname> <given-names>D.</given-names></name> <name><surname>Gayet</surname> <given-names>O.</given-names></name> <name><surname>Chabbert</surname> <given-names>M.</given-names></name> <name><surname>deLapeyri&#x00E8;re</surname> <given-names>O.</given-names></name></person-group> (<year>2006</year>). <article-title>Identification of lynx2, a novel member of the ly-6/neurotoxin superfamily, expressed in neuronal subpopulations during mouse development</article-title>. <source>Mol. Cell. Neurosci.</source> <volume>31</volume>, <fpage>232</fpage>&#x2013;<lpage>242</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mcn.2005.09.010</pub-id>, PMID: <pub-id pub-id-type="pmid">16236524</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donahue</surname> <given-names>R. J.</given-names></name> <name><surname>Landino</surname> <given-names>S. M.</given-names></name> <name><surname>Golden</surname> <given-names>S. A.</given-names></name> <name><surname>Carroll</surname> <given-names>F. I.</given-names></name> <name><surname>Russo</surname> <given-names>S. J.</given-names></name> <name><surname>Carlezon</surname> <given-names>W. A.</given-names> <suffix>Jr.</suffix></name></person-group> (<year>2015</year>). <article-title>Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system</article-title>. <source>Behav. Pharmacol.</source> <volume>26</volume>, <fpage>654</fpage>&#x2013;<lpage>663</lpage>. doi: <pub-id pub-id-type="doi">10.1097/FBP.0000000000000155</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drasdo</surname> <given-names>A.</given-names></name> <name><surname>Caulfield</surname> <given-names>M.</given-names></name> <name><surname>Bertrand</surname> <given-names>D.</given-names></name> <name><surname>Bertrand</surname> <given-names>S.</given-names></name> <name><surname>Wonnacott</surname> <given-names>S.</given-names></name></person-group> (<year>1992</year>). <article-title>Methyl lycaconitine: a novel nicotinic antagonist</article-title>. <source>Mol. Cellular Neurosci.</source> <volume>3</volume>, <fpage>237</fpage>&#x2013;<lpage>243</lpage>. doi: <pub-id pub-id-type="doi">10.1016/1044-7431(92)90043-2</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferraz Lima</surname> <given-names>M.</given-names></name> <name><surname>Castaldelli-Maia</surname> <given-names>J. M.</given-names></name> <name><surname>Apter</surname> <given-names>G.</given-names></name> <name><surname>Leopoldo</surname> <given-names>K.</given-names></name></person-group> (<year>2023</year>). <article-title>Neurobiological associations between smoking and internalizing disorders</article-title>. <source>Int. Rev. Psychiatry</source> <volume>35</volume>, <fpage>486</fpage>&#x2013;<lpage>495</lpage>. doi: <pub-id pub-id-type="doi">10.1080/09540261.2023.2252907</pub-id>, PMID: <pub-id pub-id-type="pmid">38299645</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiksdal</surname> <given-names>A.</given-names></name> <name><surname>Hanlin</surname> <given-names>L.</given-names></name> <name><surname>Kuras</surname> <given-names>Y.</given-names></name> <name><surname>Gianferante</surname> <given-names>D.</given-names></name> <name><surname>Chen</surname> <given-names>X.</given-names></name> <name><surname>Thoma</surname> <given-names>M. V.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Associations between symptoms of depression and anxiety and cortisol responses to and recovery from acute stress</article-title>. <source>Psychoneuroendocrinology</source> <volume>102</volume>, <fpage>44</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psyneuen.2018.11.035</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furini</surname> <given-names>C.</given-names></name> <name><surname>Myskiw</surname> <given-names>J.</given-names></name> <name><surname>Izquierdo</surname> <given-names>I.</given-names></name></person-group> (<year>2014</year>). <article-title>The learning of fear extinction</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>47</volume>, <fpage>670</fpage>&#x2013;<lpage>683</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.10.016</pub-id>, PMID: <pub-id pub-id-type="pmid">25452113</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gillentine</surname> <given-names>M.</given-names></name> <name><surname>Lozoya</surname> <given-names>R.</given-names></name> <name><surname>Yin</surname> <given-names>J.</given-names></name> <name><surname>Grochowski</surname> <given-names>C.</given-names></name> <name><surname>White</surname> <given-names>J.</given-names></name> <name><surname>Schaaf</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>a7 nAChRs have been linked to anxiety and depression, and CHRNA7 copy number gains have been found enriched in adolescents with major depressive and anxiety disorders</article-title>. <source>J. Affect. Disord.</source> <volume>239</volume>, <fpage>247</fpage>&#x2013;<lpage>252</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jad.2018.07.017</pub-id>, PMID: <pub-id pub-id-type="pmid">30029151</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilman</surname> <given-names>T. L.</given-names></name> <name><surname>Dutta</surname> <given-names>S.</given-names></name> <name><surname>Adkins</surname> <given-names>J. M.</given-names></name> <name><surname>Cecil</surname> <given-names>C. A.</given-names></name> <name><surname>Jasnow</surname> <given-names>A. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Basolateral amygdala Thy1-expressing neurons facilitate the inhibition of contextual fear during consolidation, reconsolidation, and extinction</article-title>. <source>Neurobiol. Learn. Mem.</source> <volume>155</volume>, <fpage>498</fpage>&#x2013;<lpage>507</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nlm.2018.09.010</pub-id>, PMID: <pub-id pub-id-type="pmid">30287384</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Golden</surname> <given-names>S. A.</given-names></name> <name><surname>Covington</surname> <given-names>H. E.</given-names></name> <name><surname>Berton</surname> <given-names>O.</given-names></name> <name><surname>Russo</surname> <given-names>S. J.</given-names></name></person-group> (<year>2011</year>). <article-title>A standardized protocol for repeated social defeat stress in mice</article-title>. <source>Nat. Protoc.</source> <volume>6</volume>, <fpage>1183</fpage>&#x2013;<lpage>1191</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nprot.2011.361</pub-id>, PMID: <pub-id pub-id-type="pmid">21799487</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grillon</surname> <given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Models and mechanisms of anxiety: evidence from startle studies</article-title>. <source>Psychopharmacology</source> <volume>199</volume>, <fpage>421</fpage>&#x2013;<lpage>437</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00213-007-1019-1</pub-id>, PMID: <pub-id pub-id-type="pmid">18058089</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grogans</surname> <given-names>S. E.</given-names></name> <name><surname>Bliss-Moreau</surname> <given-names>E.</given-names></name> <name><surname>Buss</surname> <given-names>K. A.</given-names></name> <name><surname>Clark</surname> <given-names>L. A.</given-names></name> <name><surname>Fox</surname> <given-names>A. S.</given-names></name> <name><surname>Keltner</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>(2023) the nature and neurobiology of fear and anxiety: state of the science and opportunities for accelerating discovery</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>151</volume>:<fpage>105237</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2023.105237</pub-id>, PMID: <pub-id pub-id-type="pmid">37209932</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hasco&#x00EB;t</surname> <given-names>M.</given-names></name> <name><surname>Bourin</surname> <given-names>M.</given-names></name> <name><surname>Nic Dhonnchadha</surname> <given-names>B. A.</given-names></name></person-group> (<year>2001</year>). <article-title>The mouse light-dark paradigm: a review</article-title>. <source>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</source> <volume>25</volume>, <fpage>141</fpage>&#x2013;<lpage>166</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0278-5846(00)00151-2</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heged&#x00FC;s</surname> <given-names>P.</given-names></name> <name><surname>Sviatk&#x00F3;</surname> <given-names>K.</given-names></name> <name><surname>Kir&#x00E1;ly</surname> <given-names>B.</given-names></name> <name><surname>Mart&#x00ED;nez-Bellver</surname> <given-names>S.</given-names></name> <name><surname>Hangya</surname> <given-names>B.</given-names></name></person-group> (<year>2022</year>). <article-title>Cholinergic activity reflects reward expectations and predicts behavioral responses</article-title>. <source>iScience.</source> <volume>26</volume>:<fpage>105814</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.isci.2022.105814</pub-id>, PMID: <pub-id pub-id-type="pmid">36636356</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herry</surname> <given-names>C.</given-names></name> <name><surname>Ciocchi</surname> <given-names>S.</given-names></name> <name><surname>Demou</surname> <given-names>S. V.</given-names></name> <name><surname>M&#x00FC;ller</surname> <given-names>C.</given-names></name> <name><surname>L&#x00FC;thi</surname> <given-names>A.</given-names></name></person-group> (<year>2008</year>). <article-title>Switching on and off fear by distinct neuronal circuits</article-title>. <source>Nature</source> <volume>454</volume>, <fpage>600</fpage>&#x2013;<lpage>606</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature07166</pub-id>, PMID: <pub-id pub-id-type="pmid">18615015</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname> <given-names>L. S.</given-names></name> <name><surname>Wen</surname> <given-names>J. H.</given-names></name> <name><surname>Miyares</surname> <given-names>L.</given-names></name> <name><surname>Lombroso</surname> <given-names>P. J.</given-names></name> <name><surname>Bordey</surname> <given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Outbred CD1 mice are as suitable as inbred C57BL/6J mice in performing social tasks</article-title>. <source>Neurosci. Lett.</source> <volume>637</volume>, <fpage>142</fpage>&#x2013;<lpage>147</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neulet.2016.11.035</pub-id>, PMID: <pub-id pub-id-type="pmid">27871995</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hultman</surname> <given-names>R.</given-names></name> <name><surname>Mague</surname> <given-names>S. D.</given-names></name> <name><surname>Li</surname> <given-names>Q.</given-names></name> <name><surname>Katz</surname> <given-names>B. M.</given-names></name> <name><surname>Michel</surname> <given-names>N.</given-names></name> <name><surname>Lin</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Dysregulation of prefrontal cortex-mediated slow-evolving limbic dynamics drives stress-induced emotional pathology</article-title>. <source>Neuron</source> <volume>91</volume>, <fpage>439</fpage>&#x2013;<lpage>452</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2016.05.038</pub-id>, PMID: <pub-id pub-id-type="pmid">27346529</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hultman</surname> <given-names>R.</given-names></name> <name><surname>Ulrich</surname> <given-names>K.</given-names></name> <name><surname>Sachs</surname> <given-names>B. D.</given-names></name> <name><surname>Blount</surname> <given-names>C.</given-names></name> <name><surname>Carlson</surname> <given-names>D. E.</given-names></name> <name><surname>Ndubuizu</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Brain-wide electrical spatiotemporal dynamics encode depression vulnerability</article-title>. <source>Cell</source> <volume>173</volume>, <fpage>166</fpage>&#x2013;<lpage>180</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2018.02.012</pub-id>, PMID: <pub-id pub-id-type="pmid">29502969</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iba&#x00F1;ez-Tallon</surname> <given-names>I.</given-names></name> <name><surname>Miwa</surname> <given-names>J. M.</given-names></name> <name><surname>Wang</surname> <given-names>H. L.</given-names></name> <name><surname>Adams</surname> <given-names>N. C.</given-names></name> <name><surname>Crabtree</surname> <given-names>G. W.</given-names></name> <name><surname>Sine</surname> <given-names>S. M.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1</article-title>. <source>Neuron</source> <volume>33</volume>, <fpage>893</fpage>&#x2013;<lpage>903</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0896-6273(02)00632-3</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jasnow</surname> <given-names>A. M.</given-names></name> <name><surname>Chanjun</surname> <given-names>S.</given-names></name> <name><surname>Jeris</surname> <given-names>I.</given-names></name> <name><surname>Michael</surname> <given-names>D.</given-names></name> <name><surname>Huhman</surname> <given-names>K. L.</given-names></name></person-group> (<year>2005</year>). <article-title>Memory of social defeat is facilitated by cAMP response element-binding protein overexpression in the amygdala</article-title>. <source>Behav. Neurosci.</source> <volume>119</volume>, <fpage>1125</fpage>&#x2013;<lpage>1130</lpage>. doi: <pub-id pub-id-type="doi">10.1037/0735-7044.119.4.1125</pub-id>, PMID: <pub-id pub-id-type="pmid">16187840</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jasnow</surname> <given-names>A. M.</given-names></name> <name><surname>Cooper</surname> <given-names>M. A.</given-names></name> <name><surname>Huhman</surname> <given-names>K. L.</given-names></name></person-group> (<year>2004</year>). <article-title>N-methyl-d-aspartate receptors in the amygdala are necessary for the acquisition and expression of conditioned defeat</article-title>. <source>Neuroscience</source> <volume>123</volume>, <fpage>625</fpage>&#x2013;<lpage>634</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroscience.2003.10.015</pub-id>, PMID: <pub-id pub-id-type="pmid">14706775</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>L.</given-names></name> <name><surname>Kundu</surname> <given-names>S.</given-names></name> <name><surname>Lederman</surname> <given-names>J. D.</given-names></name> <name><surname>L&#x00F3;pez-Hern&#x00E1;ndez</surname> <given-names>G. Y.</given-names></name> <name><surname>Ballinger</surname> <given-names>E. C.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Cholinergic signaling controls conditioned fear behaviors and enhances plasticity of cortical-amygdala circuits</article-title>. <source>Neuron</source> <volume>90</volume>, <fpage>1057</fpage>&#x2013;<lpage>1070</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.028</pub-id>, PMID: <pub-id pub-id-type="pmid">27161525</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname> <given-names>R. C.</given-names></name> <name><surname>Petukhova</surname> <given-names>M.</given-names></name> <name><surname>Sampson</surname> <given-names>N. A.</given-names></name> <name><surname>Zaslavsky</surname> <given-names>A. M.</given-names></name> <name><surname>Wittchen</surname> <given-names>H. U.</given-names></name></person-group> (<year>2012</year>). <article-title>Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States</article-title>. <source>Int. J. Methods Psychiatr. Res.</source> <volume>21</volume>, <fpage>169</fpage>&#x2013;<lpage>184</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mpr.1359</pub-id>, PMID: <pub-id pub-id-type="pmid">22865617</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalifeh</surname> <given-names>M.</given-names></name> <name><surname>Hobeika</surname> <given-names>R.</given-names></name> <name><surname>El Hayek</surname> <given-names>L.</given-names></name> <name><surname>Saad</surname> <given-names>J.</given-names></name> <name><surname>Eid</surname> <given-names>F.</given-names></name> <name><surname>El-Khoury</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Nicotine induces resilience to chronic social defeat stress in a mouse model of water pipe tobacco exposure by activating BDNF signaling</article-title>. <source>Behav. Brain Res.</source> <volume>382</volume>:<fpage>112499</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2020.112499</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J.</given-names></name> <name><surname>Lee</surname> <given-names>S.</given-names></name> <name><surname>Park</surname> <given-names>K.</given-names></name> <name><surname>Hong</surname> <given-names>I.</given-names></name> <name><surname>Song</surname> <given-names>B.</given-names></name> <name><surname>Son</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Amygdala depotentiation and fear extinction</article-title>. <source>Proc. Nat. Acad. Sci. U. S. A.</source> <volume>104</volume>, <fpage>20955</fpage>&#x2013;<lpage>20960</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0710548105</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname> <given-names>J. W.</given-names></name> <name><surname>Chaudhury</surname> <given-names>D.</given-names></name> <name><surname>Han</surname> <given-names>M. H.</given-names></name> <name><surname>Nestler</surname> <given-names>E. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Role of mesolimbic brain-derived neurotrophic factor in depression</article-title>. <source>Biol. Psychiatry</source> <volume>86</volume>, <fpage>738</fpage>&#x2013;<lpage>748</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsych.2019.05.020</pub-id>, PMID: <pub-id pub-id-type="pmid">31327473</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koo Wook</surname> <given-names>J. W.</given-names></name> <name><surname>Benoit Labont&#x00E9;</surname> <given-names>B.</given-names></name> <name><surname>Olivia Engmann</surname> <given-names>O.</given-names></name> <name><surname>Erin</surname> <given-names>S.</given-names></name> <name><surname>Calipari</surname> <given-names>E. S.</given-names></name> <name><surname>Barbara Juarez</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Essential Role of mesolimbic brain-derived neurotrophic factor in chronic social stress&#x2013;induced depressive behaviors</article-title>. <source>Biol. Psychiatry</source> <volume>80</volume>, <fpage>469</fpage>&#x2013;<lpage>478</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.12.009</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krabbe</surname> <given-names>S.</given-names></name> <name><surname>Gr&#x00FC;ndemann</surname> <given-names>J.</given-names></name> <name><surname>L&#x00FC;thi</surname> <given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Amygdala inhibitory circuits regulate associative fear conditioning</article-title>. <source>Biol. Psychiatry</source> <volume>83</volume>, <fpage>800</fpage>&#x2013;<lpage>809</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.10.006</pub-id>, PMID: <pub-id pub-id-type="pmid">29174478</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname> <given-names>V.</given-names></name> <name><surname>Han</surname> <given-names>M. H.</given-names></name> <name><surname>Graham</surname> <given-names>D. L.</given-names></name> <name><surname>Berton</surname> <given-names>O.</given-names></name> <name><surname>Renthal</surname> <given-names>W.</given-names></name> <name><surname>Russo</surname> <given-names>S. J.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions</article-title>. <source>Cell</source> <volume>131</volume>, <fpage>391</fpage>&#x2013;<lpage>404</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2007.09.018</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kutlu</surname> <given-names>M. G.</given-names></name> <name><surname>Gould</surname> <given-names>T. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Acute nicotine delays extinction of contextual fear in mice</article-title>. <source>Behav. Brain Res.</source> <volume>263</volume>, <fpage>133</fpage>&#x2013;<lpage>137</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2014.01.031</pub-id>, PMID: <pub-id pub-id-type="pmid">24487010</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kutlu</surname> <given-names>M. G.</given-names></name> <name><surname>Gould</surname> <given-names>T. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Nicotine modulation of fear memories and anxiety: implications for learning and anxiety disorders</article-title>. <source>Biochem. Pharmacol.</source> <volume>97</volume>, <fpage>498</fpage>&#x2013;<lpage>511</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bcp.2015.07.029</pub-id>, PMID: <pub-id pub-id-type="pmid">26231942</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lagace</surname> <given-names>D. C.</given-names></name> <name><surname>Donovan</surname> <given-names>M. H.</given-names></name> <name><surname>DeCarolis</surname> <given-names>N. A.</given-names></name> <name><surname>Farnbauch</surname> <given-names>L. A.</given-names></name> <name><surname>Malhotra</surname> <given-names>S.</given-names></name> <name><surname>Berton</surname> <given-names>O.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Adult hippocampal neurogenesis is functionally important for stress-induced social avoidance</article-title>. <source>PNAS</source> <volume>107</volume>, <fpage>4436</fpage>&#x2013;<lpage>4441</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0910072107</pub-id>, PMID: <pub-id pub-id-type="pmid">20176946</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Letzkus</surname> <given-names>J. J.</given-names></name> <name><surname>Wolff</surname> <given-names>S. B. E.</given-names></name> <name><surname>Meyer</surname> <given-names>E. M.</given-names></name> <name><surname>Tovote</surname> <given-names>P.</given-names></name> <name><surname>Courtin</surname> <given-names>J.</given-names></name> <name><surname>Herry</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>A disinhibitory microcircuit for associative fear learning in the auditory cortex</article-title>. <source>Nature</source> <volume>480</volume>, <fpage>331</fpage>&#x2013;<lpage>335</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature10674</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lissek</surname> <given-names>S.</given-names></name> <name><surname>Powersb</surname> <given-names>A. S.</given-names></name> <name><surname>McMlurea</surname> <given-names>E. B.</given-names></name> <name><surname>Phelosc</surname> <given-names>E. A.</given-names></name> <name><surname>Woldehawariata</surname> <given-names>G.</given-names></name> <name><surname>Frillona</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Classical fear conditioning in the anxiety disorders: a meta-analysis</article-title>. <source>Behav. Res. Ther.</source> <volume>43</volume>, <fpage>1391</fpage>&#x2013;<lpage>1424</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brat.2004.10.007</pub-id>, PMID: <pub-id pub-id-type="pmid">15885654</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mallei</surname> <given-names>A.</given-names></name> <name><surname>Ieraci</surname> <given-names>A.</given-names></name> <name><surname>Popoli</surname> <given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Chronic social defeat stress differentially regulates the expression of&#x202F;BDNF&#x202F;transcripts and epigenetic modifying enzymes in susceptible and resilient mice</article-title>. <source>World J. Biol. Psychiatr. Offi. Federation Soc. Biol. Psychiatry</source> <volume>20</volume>, <fpage>555</fpage>&#x2013;<lpage>566</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15622975.2018.1500029</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maren</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Out with the old and in with the new: synaptic mechanisms of extinction in the amygdala</article-title>. <source>Brain Res.</source> <volume>1621</volume>, <fpage>231</fpage>&#x2013;<lpage>238</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.brainres.2014.10.010</pub-id>, PMID: <pub-id pub-id-type="pmid">25312830</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Markett</surname> <given-names>S.</given-names></name> <name><surname>Montag</surname> <given-names>C.</given-names></name> <name><surname>Reuter</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>The nicotinic acetylcholine receptor gene CHRNA4 is associated with negative emotionality</article-title>. <source>Emotion</source> <volume>11</volume>, <fpage>450</fpage>&#x2013;<lpage>455</lpage>. doi: <pub-id pub-id-type="doi">10.1037/a0021784</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maron</surname> <given-names>E.</given-names></name> <name><surname>Nutt</surname> <given-names>D.</given-names></name></person-group> (<year>2017</year>). <article-title>Biological markers of generalized anxiety disorder</article-title>. <source>Dialogues Clin. Neurosci.</source> <volume>19</volume>, <fpage>147</fpage>&#x2013;<lpage>158</lpage>. doi: <pub-id pub-id-type="doi">10.31887/DCNS.2017.19.2/dnutt</pub-id>, PMID: <pub-id pub-id-type="pmid">28867939</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McEwen</surname> <given-names>B. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Neurobiological and systemic effects of chronic stress</article-title>. <source>Chronic Stress</source> <volume>1</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1177/2470547017692328</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meduri</surname> <given-names>J. D.</given-names></name> <name><surname>Farnbauch</surname> <given-names>L. A.</given-names></name> <name><surname>Jasnow</surname> <given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Paradoxical enhancement of fear expression and extinction deficits in mice resilient to social defeat</article-title>. <source>Behav. Brain Res.</source> <volume>256</volume>, <fpage>580</fpage>&#x2013;<lpage>590</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2013.09.009</pub-id>, PMID: <pub-id pub-id-type="pmid">24029700</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mineur</surname> <given-names>Y. S.</given-names></name> <name><surname>Fote</surname> <given-names>G. M.</given-names></name> <name><surname>Blakeman</surname> <given-names>S.</given-names></name> <name><surname>Cahuzac</surname> <given-names>E. L. M.</given-names></name> <name><surname>Newbold</surname> <given-names>S. A.</given-names></name> <name><surname>Picciotto</surname> <given-names>M. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Multiple nicotinic acetylcholine receptor subtypes in the mouse amygdala regulate affective behaviors and response to social stress</article-title>. <source>Neuropsychopharmacology</source> <volume>41</volume>, <fpage>1579</fpage>&#x2013;<lpage>1587</lpage>. doi: <pub-id pub-id-type="doi">10.1038/npp.2015.316</pub-id>, PMID: <pub-id pub-id-type="pmid">26471256</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mineur</surname> <given-names>Y. S.</given-names></name> <name><surname>Picciotto</surname> <given-names>M. R.</given-names></name></person-group> (<year>2019</year>). <article-title>The Role of acetylcholine in negative encoding Bias: too much of a good thing?</article-title> <source>Eur. J. Neurosci.</source> <volume>53</volume>, <fpage>114</fpage>&#x2013;<lpage>125</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ejn.14641</pub-id></citation></ref>
<ref id="ref0071"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mineur</surname> <given-names>Y. S.</given-names></name> <name><surname>Soares</surname> <given-names>A. R.</given-names></name> <name><surname>Etherington</surname> <given-names>I. M.</given-names></name> <name><surname>Abdulla</surname> <given-names>Z. I.</given-names></name> <name><surname>Picciotto</surname> <given-names>M. R.</given-names></name></person-group> (<year>2023</year>). <article-title>Pathophysiology of nAChRs: Limbic circuits and related disorders</article-title>. <source>Pharmacological research</source>, <volume>191</volume>:<fpage>106745</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phrs.2023.106745</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miwa</surname> <given-names>J. M.</given-names></name> <name><surname>Stevens</surname> <given-names>T. R.</given-names></name> <name><surname>King</surname> <given-names>S. L.</given-names></name> <name><surname>Caldarone</surname> <given-names>B. J.</given-names></name> <name><surname>Ibanez-Tallon</surname> <given-names>I.</given-names></name> <name><surname>Xiao</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo</article-title>. <source>Neuron</source> <volume>51</volume>, <fpage>587</fpage>&#x2013;<lpage>600</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2006.07.025</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monkol</surname> <given-names>L.</given-names></name> <name><surname>Karczewski</surname> <given-names>K. J.</given-names></name> <name><surname>Minikel</surname> <given-names>E. V.</given-names></name> <name><surname>Samocha</surname> <given-names>K. E.</given-names></name> <name><surname>Banks</surname> <given-names>E.</given-names></name> <name><surname>Fennell</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source>Nature</source> <volume>536</volume>, <fpage>285</fpage>&#x2013;<lpage>291</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature19057</pub-id>, PMID: <pub-id pub-id-type="pmid">27535533</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morishita</surname> <given-names>H.</given-names></name> <name><surname>Miwa</surname> <given-names>J. M.</given-names></name> <name><surname>Heintz</surname> <given-names>N.</given-names></name> <name><surname>Hensch</surname> <given-names>T. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Lynx1, a cholinergic brake limits plasticity in adult visual cortex: (a cure for amblyopia through nicotinic receptor signaling)</article-title>. <source>Science</source> <volume>330</volume>, <fpage>1238</fpage>&#x2013;<lpage>1240</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1195320</pub-id>, PMID: <pub-id pub-id-type="pmid">21071629</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Numa</surname> <given-names>C.</given-names></name> <name><surname>Nagai</surname> <given-names>H.</given-names></name> <name><surname>Taniguchi</surname> <given-names>M.</given-names></name> <name><surname>Nagai</surname> <given-names>M.</given-names></name> <name><surname>Furuyashiki</surname> <given-names>T.</given-names></name></person-group> (<year>2019</year>). <article-title>(2019) social defeat stress-specific increase in c-Fos expression in the extended amygdala in mice: involvement of dopamine D1 receptor in the medial prefrontal cortex</article-title>. <source>Sci. Rep.</source> <volume>9</volume>:<fpage>16670</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-52997-7</pub-id>, PMID: <pub-id pub-id-type="pmid">31723165</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x2019;Leary</surname> <given-names>T. P.</given-names></name> <name><surname>Gunn</surname> <given-names>R. K.</given-names></name> <name><surname>Brown</surname> <given-names>R. E.</given-names></name></person-group> (<year>2013</year>). <article-title>What are we measuring when we test strain differences in anxiety in mice?</article-title> <source>Behav. Genet.</source> <volume>43</volume>, <fpage>34</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10519-012-9572-8</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Omori</surname> <given-names>S. A.</given-names></name> <name><surname>Iwasawa</surname> <given-names>O.</given-names></name> <name><surname>Saito</surname> <given-names>H.</given-names></name> <name><surname>Nakajima</surname> <given-names>H.</given-names></name> <name><surname>Matsuno</surname> <given-names>A.</given-names></name> <name><surname>Sato</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Association of serum Ly6/PLAUR domain-containing protein 1 levels with skin sclerosis in systemic sclerosis</article-title>. <source>Sci. Rep.</source> <volume>14</volume>:<fpage>5572</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-024-56221-z</pub-id>, PMID: <pub-id pub-id-type="pmid">38448661</pub-id></citation></ref>
<ref id="ref64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ortiz</surname> <given-names>V.</given-names></name> <name><surname>Costa Campos</surname> <given-names>R.</given-names></name> <name><surname>Fofo</surname> <given-names>H.</given-names></name> <name><surname>Fernandez</surname> <given-names>S. P.</given-names></name> <name><surname>Barik</surname> <given-names>J.</given-names></name></person-group> (<year>2022</year>). <article-title>Nicotinic receptors promote susceptibility to social stress in female mice linked with neuroadaptations within VTA dopamine neurons</article-title>. <source>Neuropsychopharmacology</source> <volume>47</volume>, <fpage>1587</fpage>&#x2013;<lpage>1596</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41386-022-01314-4</pub-id>, PMID: <pub-id pub-id-type="pmid">35459925</pub-id></citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pagliusi</surname> <given-names>M. O. F.</given-names></name> <name><surname>Bonet</surname> <given-names>I. J. M.</given-names></name> <name><surname>Dias</surname> <given-names>E. V.</given-names></name> <name><surname>Vieira</surname> <given-names>A. S.</given-names></name> <name><surname>Tambeli</surname> <given-names>C. H.</given-names></name> <name><surname>Parada</surname> <given-names>C. A.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Social defeat stress induces hyperalgesia and increases truncated BDNF isoforms in the nucleus accumbens regardless of the depressive-like behavior induction in mice</article-title>. <source>Eur. J. Neurosci.</source> <volume>48</volume>, <fpage>1635</fpage>&#x2013;<lpage>1646</lpage>. doi: <pub-id pub-id-type="doi">10.1111/ejn.13994</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pagliusi</surname> <given-names>M. O. F.</given-names></name> <name><surname>Sartori</surname> <given-names>C. R.</given-names></name></person-group> (<year>2019</year>). <article-title>Social defeat stress (SDS) in mice: using Swiss mice as resident</article-title>. <source>Bio-protocol</source> <volume>9</volume>:<fpage>e3197</fpage>. doi: <pub-id pub-id-type="doi">10.21769/BioProtoc.3197</pub-id>, PMID: <pub-id pub-id-type="pmid">33654995</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>L.</given-names></name> <name><surname>Ngolab</surname> <given-names>J.</given-names></name> <name><surname>Zhao-Shea</surname> <given-names>R.</given-names></name> <name><surname>McIntosh</surname> <given-names>J. M.</given-names></name> <name><surname>Gardner</surname> <given-names>P. D.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Habenula cholinergic neurons regulate anxiety during nicotine withdrawal via nicotinic acetylcholine receptors</article-title>. <source>Neuropharmacology</source> <volume>107</volume>, <fpage>294</fpage>&#x2013;<lpage>304</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.03.039</pub-id>, PMID: <pub-id pub-id-type="pmid">27020042</pub-id></citation></ref>
<ref id="ref68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pantoni</surname> <given-names>M. M.</given-names></name> <name><surname>Herrera</surname> <given-names>G. M.</given-names></name> <name><surname>Van Alstyne</surname> <given-names>K. R.</given-names></name> <name><surname>Anagnostaras</surname> <given-names>S. G.</given-names></name></person-group> (<year>2020</year>). <article-title>Quantifying the acoustic startle response in mice using standard digital video</article-title>. <source>Front. Behav. Neurosci.</source> <volume>14</volume>:<fpage>83</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2020.00083</pub-id></citation></ref>
<ref id="ref69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Picciotto</surname> <given-names>M. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Nicotine as a modulator of behavior: beyond the inverted U</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>24</volume>, <fpage>493</fpage>&#x2013;<lpage>499</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0165-6147(03)00230-X</pub-id>, PMID: <pub-id pub-id-type="pmid">12967775</pub-id></citation></ref>
<ref id="ref70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pisapati</surname> <given-names>A. V.</given-names></name> <name><surname>Cao</surname> <given-names>W.</given-names></name> <name><surname>Anderson</surname> <given-names>K. R.</given-names></name> <name><surname>Jones</surname> <given-names>G.</given-names></name> <name><surname>Holick</surname> <given-names>K. H.</given-names></name> <name><surname>Whiteaker</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Biophysical characterization of lynx-nicotinic receptor interactions using atomic force microscopy</article-title>. <source>FASEB Bio Adva.</source> <volume>3</volume>, <fpage>1034</fpage>&#x2013;<lpage>1042</lpage>. doi: <pub-id pub-id-type="doi">10.1096/fba.2021-00012</pub-id></citation></ref>
<ref id="ref71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname> <given-names>G.</given-names></name> <name><surname>Zhang</surname> <given-names>P.</given-names></name> <name><surname>Li</surname> <given-names>T.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Zhang</surname> <given-names>Q.</given-names></name> <name><surname>He</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>NAc-VTA circuit underlies emotional stress-induced anxiety-like behavior in the three-chamber vicarious social defeat stress mouse model</article-title>. <source>Nat. Commun.</source> <volume>13</volume>:<fpage>577</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-022-28190-2</pub-id>, PMID: <pub-id pub-id-type="pmid">35102141</pub-id></citation></ref>
<ref id="ref72"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Ree</surname> <given-names>M. J.</given-names></name> <name><surname>French</surname> <given-names>D.</given-names></name> <name><surname>MacLeod</surname> <given-names>C.</given-names></name> <name><surname>Locke</surname> <given-names>V.</given-names></name></person-group> (<year>2008</year>). State&#x2013;Trait Inventory for Cognitive and Somatic Anxiety (STICSA) [Database record]. <source>APA PsycTests.</source> <volume>24</volume>:<fpage>1184</fpage> doi: <pub-id pub-id-type="doi">10.1037/t01184-000</pub-id></citation></ref>
<ref id="ref73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>O. J.</given-names></name> <name><surname>Pike</surname> <given-names>A. C.</given-names></name> <name><surname>Cornwell</surname> <given-names>B.</given-names></name> <name><surname>Grillon</surname> <given-names>C.</given-names></name></person-group> (<year>2019</year>). <article-title>The translational neural circuitry of anxiety</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source> <volume>90</volume>:<fpage>jnnp-2019-321400</fpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp-2019-321400</pub-id>, PMID: <pub-id pub-id-type="pmid">31256001</pub-id></citation></ref>
<ref id="ref74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saha</surname> <given-names>R.</given-names></name> <name><surname>Knapp</surname> <given-names>S.</given-names></name> <name><surname>Chakraborty</surname> <given-names>D.</given-names></name> <name><surname>Horovitz</surname> <given-names>O.</given-names></name> <name><surname>Albrecht</surname> <given-names>A.</given-names></name> <name><surname>Kriebel</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>GABAergic synapses at the axon initial segment of basolateral amygdala projection neurons modulate fear extinction</article-title>. <source>Neuropsychopharmacology</source> <volume>42</volume>, <fpage>473</fpage>&#x2013;<lpage>484</lpage>. doi: <pub-id pub-id-type="doi">10.1038/npp.2016.205</pub-id>, PMID: <pub-id pub-id-type="pmid">27634356</pub-id></citation></ref>
<ref id="ref75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schneiderman</surname> <given-names>N.</given-names></name> <name><surname>Ironson</surname> <given-names>G.</given-names></name> <name><surname>Siegel</surname> <given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Stress and health: psychological, behavioral, and biological determinants</article-title>. <source>Annu. Rev. Clin. Psychol.</source> <volume>1</volume>, <fpage>607</fpage>&#x2013;<lpage>628</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.clinpsy.1.102803.144141</pub-id>, PMID: <pub-id pub-id-type="pmid">17716101</pub-id></citation></ref>
<ref id="ref76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sherafat</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>E.</given-names></name> <name><surname>Lallai</surname> <given-names>V.</given-names></name> <name><surname>Bautista</surname> <given-names>M.</given-names></name> <name><surname>Fowler</surname> <given-names>J. P.</given-names></name> <name><surname>Chen</surname> <given-names>Y. C.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Differential expression patterns of Lynx proteins and involvement of Lynx1 in Prepulse inhibition</article-title>. <source>Front. Behav. Neurosci.</source> <volume>15</volume>:<fpage>703748</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2021.703748</pub-id>, PMID: <pub-id pub-id-type="pmid">34803621</pub-id></citation></ref>
<ref id="ref77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>Z.</given-names></name> <name><surname>Gui</surname> <given-names>S.</given-names></name> <name><surname>Xiao</surname> <given-names>S.</given-names></name> <name><surname>Rao</surname> <given-names>X.</given-names></name> <name><surname>Cong</surname> <given-names>N.</given-names></name> <name><surname>Deng</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer</article-title>. <source>Sci. Rep.</source> <volume>14</volume>:<fpage>3198</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-024-53272-0</pub-id>, PMID: <pub-id pub-id-type="pmid">38332160</pub-id></citation></ref>
<ref id="ref78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname> <given-names>D. J.</given-names></name> <name><surname>Scott</surname> <given-names>K. M.</given-names></name> <name><surname>de Jonge</surname> <given-names>P.</given-names></name> <name><surname>Kessler</surname> <given-names>R. C.</given-names></name></person-group> (<year>2017</year>, <year>2017</year>). <article-title>Epidemiology of anxiety disorders: from surveys to nosology and back</article-title>. <source>Dialogues Clin. Neurosci.</source> <volume>19</volume>, <fpage>127</fpage>&#x2013;<lpage>136</lpage>. doi: <pub-id pub-id-type="doi">10.31887/DCNS.2017.19.2/dstein</pub-id></citation></ref>
<ref id="ref79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname> <given-names>A.</given-names></name> <name><surname>Chung</surname> <given-names>J.-R.</given-names></name> <name><surname>Zhang</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>H.</given-names></name> <name><surname>Grossman</surname> <given-names>Y.</given-names></name> <name><surname>Aleyasin</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Establishment of a repeated social defeat stress model in female mice</article-title>. <source>Sci. Rep.</source> <volume>7</volume>:<fpage>12838</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-017-12811-8</pub-id>, PMID: <pub-id pub-id-type="pmid">28993631</pub-id></citation></ref>
<ref id="ref80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tekinay</surname> <given-names>A. B.</given-names></name> <name><surname>Nong</surname> <given-names>Y.</given-names></name> <name><surname>Miwa</surname> <given-names>J. M.</given-names></name> <name><surname>Lieberam</surname> <given-names>I.</given-names></name> <name><surname>Ibanez-Tallon</surname> <given-names>I.</given-names></name> <name><surname>Greengard</surname> <given-names>P.</given-names></name> <name><surname>Heintz</surname> <given-names>N.</given-names></name></person-group> (<year>2009</year>). <article-title>A role for LYNX2 in anxiety-related behavior</article-title>. <source>Proc. Nat. Acad. Sci. U. S. A.</source>, <volume>106</volume>, <fpage>4477</fpage>&#x2013;<lpage>4482</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0813109106</pub-id></citation></ref>
<ref id="ref81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turek</surname> <given-names>F. W.</given-names></name> <name><surname>Penev</surname> <given-names>P.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>van Reeth</surname> <given-names>O.</given-names></name> <name><surname>Zee</surname> <given-names>P.</given-names></name></person-group> (<year>1995</year>). <article-title>Effects of age on the circadian system</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>19</volume>, <fpage>53</fpage>&#x2013;<lpage>58</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0149-7634(94)00030-5</pub-id></citation></ref>
<ref id="ref82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Min</surname> <given-names>S.</given-names></name> <name><surname>Zhang</surname> <given-names>D.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Niu</surname> <given-names>C.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>The cation channel mechanisms of subthreshold inward depolarizing currents in the VTA dopaminergic neurons and their roles in the chronic-stress-induced depression-like behavior</article-title>. <source>Life</source> <volume>12</volume>:<fpage>RP88319</fpage>. doi: <pub-id pub-id-type="doi">10.7554/eLife.88319.3</pub-id></citation></ref>
<ref id="ref83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>M. A.</given-names></name> <name><surname>Fadel</surname> <given-names>J. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Cholinergic regulation of fear learning and extinction</article-title>. <source>J. Neurosci. Res.</source> <volume>95</volume>, <fpage>836</fpage>&#x2013;<lpage>852</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jnr.23840</pub-id></citation></ref>
<ref id="ref84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>M.</given-names></name> <name><surname>Puddifoot</surname> <given-names>C. A.</given-names></name> <name><surname>Taylor</surname> <given-names>P.</given-names></name> <name><surname>Joiner</surname> <given-names>W. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Mechanisms of inhibition and potentiation of &#x03B1;4&#x03B2;2 nicotinic acetylcholine receptors by members of the Ly6 protein family</article-title>. <source>J. Biol. Chem.</source> <volume>290</volume>, <fpage>24509</fpage>&#x2013;<lpage>24518</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M115.647248</pub-id>, PMID: <pub-id pub-id-type="pmid">26276394</pub-id></citation></ref>
<ref id="ref85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>T.</given-names></name> <name><surname>Gao</surname> <given-names>X.</given-names></name> <name><surname>Huang</surname> <given-names>G. B.</given-names></name></person-group> (<year>2021</year>). <article-title>(2021) effects of chronic social defeat stress on behavior and dopamine receptors in adolescent mice with 6-Hydroxydopamine lesions of the medial prefrontal cortex</article-title>. <source>Front. Behav. Neurosci.</source> <volume>15</volume>:<fpage>731373</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2021.731373</pub-id></citation></ref>
<ref id="ref86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>G.</given-names></name> <name><surname>Briz</surname> <given-names>V.</given-names></name> <name><surname>Seinfeld</surname> <given-names>J.</given-names></name> <name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Bi</surname> <given-names>X.</given-names></name> <name><surname>Baudry</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Calpain-1 deletion impairs mGluR-dependent LTD and fear memory extinction</article-title>. <source>Sci. Rep.</source> <volume>7</volume>:<fpage>42788</fpage>. doi: <pub-id pub-id-type="doi">10.1038/srep42788</pub-id>, PMID: <pub-id pub-id-type="pmid">28202907</pub-id></citation></ref>
</ref-list>
</back>
</article>